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ABSTRACT 
STRUCTURAL AND FUNCTIONAL ANALYSIS 
OF SECONDARY STRUCTURE BLOCK TO mRNA UTILIZATION 
by 
Juan Lin 
Experimentally introduced secondary structure, formed by a cis-targeted 
hammerhead ribozyme in exon 2 two nucleotides dowstream of the 3' splice 
site of a yeast ACT-E. coli /acZfusion gene, virtually abolishes splicing in vivo 
and inhibits B-galactosidase production. This is the first demonstration of the 
splicing inhibitory effect of secondary structures occurring in exons in the 
absence of splice site sequestration. Our goal is to understand the mechanism 
by which utilization of this splice site is impeded. Two cis - and one trans-acting 
mutations that alleviate the splicing blockage were obtained by screening for 
restoration of B-galactosidase activity. Both cis-acting mutations potentially 
destabilize the stem in the region close to the 3' splice site. Combined with the 
results from other artificially constructed cis-acting mutants, this finding suggests 
that (1) splicing is inhibited by formation of the RNA secondary structures and 
(2) the extent of inhibition is directly related to the stablility of the secondary 
structures. Our results also indicate that there may be a general phenomenon 
of exon 2 secondary structure-specific splicing regulation. 
The trans-acting mutation, designated rss1-1, restores B-galactosidase 
expression by both increasing the splicing efficiency and stabilizing the 
precursor and lariat intermediate. The gene encoding the trans-acting mutant 
protein has been cloned. The RSS1 gene is located on Saccharomyces 
cerevisiae chromosome V; and is a single copy, essential gene. The predicted 
RSS1 amino acid sequence has marked similarity to members of the putative 
ATP-dependent RNA helicase family. The trans-acting suppression activity of 
rss1-1 is highly allele-specific for the secondary structure of the hammerhead 
ribozyme. Different secondary structures, which also block splicing, are not 
suppressed by the rss1-1 allele. The single nucleotide change that confers the 
rss 1-1 suppresssor phenotype produces a Gly to Arg substitution near the 
GRAGR consensus motif. Thus, the GRAGR region might be involved in RNA 
substrate interaction. Two alternative models for suppression of the splicing 




A. Pre-mRNA splicing 
1. The Landmark Discovery 
The discovery of pre-mRNA splicing was made two decades ago during 
analysis of adenovirus late transcripts (Berget et al., 1977). In these studies, 
Philip Sharp and colleagues gel purified the viral mRNA encoding the hexon 
polypeptide, a major virion structural protein. To map the region of the viral DNA 
encoding this protein, they hybridized hexon mRNA and single-stranded 
fragments of viral DNA. The RNA-DNA hybrid was visualized by electron 
microscopy. Three loops of single-stranded DNA failed to hydrogen bond to 
mRNA. These are the three intron sequences in the adenovirus viral DNA that 
are spliced out during the synthesis of mature hexon mRNA. Philip Sharp and 
Richard Roberts were awarded the Noble Prize in 1993 for this landmark 
discovery. 
Soon after the initial discovery of pre-mRNA splicing in adenovirus, 
splicing was reported in other viral genomes, rRNA genes, tRNA genes and 
chromosomal genes (for reviews see Abelson, 1979; Flint, 1983). RNA splicing 
was immediately realized to be a general phenomenon, an essential step in 
RNA processing (Abelson, 1979; Flint, 1983). 
1 
2 
2. The Mechanism of Splicing 
Within the following few years our understanding of the splicing 
mechanism was rapidly advanced, largely due to the development of 
mammalian in vitro splicing systems (for review see Green, 1986). The ability to 
synthesize abundant unspliced RNA was made possible through efficient 
prokaryotic in vitro transcription systems (Kassavetis et al., 1982). A method for 
preparing whole-cell extracts (Kole et al., 1982; Padgett et al., 1983) and 
nuclear extracts (Hernandez et al., 1983; Krainer et al., 1984) that support the 
pre-mRNA splicing reaction was developed. The availability of cell-free extracts, 
which could accurately splice exogenous pre-mRNAs in vitro, led to almost 
immediate progress in direct characterization of pre-mRNA splicing 
intermediates and products. A whole-cell extract from yeast cells that enables 
accurate and efficient pre-mRNA splicing was also developed (Lin et al., 1985). 
A two-step mechanism of pre-mRNA splicing was then revealed by these 
in vitro systems (Fig. 1 ). All introns within nuclear mRNA precursors are 
removed via two successive transesterification reactions (Grabowski et al., 
1984; Padgett et al., 1984; Ruskin et al., 1984; Konarska et al., 1985; Sharp 
1987; Moore and Sharp 1993). In the first step, the phosphate at the 5' splice 
site is attacked by the 2' hydroxyl group of an internal adenosine residue. This 
generates the 5' exon and a branched intron with attached 3' exon, which is 
called the lariat intermediate. In the second step, the 3' hydroxyl of the 5' exon 
attacks the phosphate at the 3' splice site yielding two products: spliced exons 
and the excised lariat intron. 
3 
Exon 1 A Exon2 
i Step 1 
Q Exon 1 
Exon 2 
i Step2 
Exon 1 Exon 2 Q 
Figure 1. Two chemical steps of splicing reaction. 
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3. ATP-Dependence of Splicing Reaction 
It has been known for many years that pre-mRNA splicing requires ATP 
hydrolysis (Sawa et al., 1988). Interestingly, there is no net change in the 
number of phosphodiester bonds formed or broken in the splicing reaction 
(Padgett et al., 1984; Konarska et al., 1985; Lin et al., 1985). ATP hydrolysis is 
required in nearly every step of the spliceosome assembly pathway and the two 
catalytic steps. These steps include the stable binding of U2 snRNP to the 
pre-mRNA (Konarska & Sharp, 1986; Cheng & Abelson, 1987), the binding of 
the tripartite U4-U5-U6 snRNPs (Konarska & Sharp, 1987; Cheng & Abelson, 
1987), the release of the U4 snRNP just prior to the two chemical steps {Cheng 
& Abelson, 1987; Brow & Guthrie, 1988) and the stage just prior to the second 
step of splicing (Schwer & Guthrie, 1992). 
4. Conserved Sequences At The 5' Splice Sites 
The process of RNA splicing requires accurate splice site selection and 
cleavage. A major determinant of splice site selection is conserved RNA 
sequences at the two splice sites (Fig. 2) (Breathnach et al., 1978). The role of 
conserved sequence elements in pre-mRNA splicing was demonstrated by 
sequence comparisons of genes and by mutagenesis of the sequence 
elements. 
A comparison of 5' intron-exon junctions in mammals identified a 5' 
splice-junction sequence: AG/GURAGU (/ denotes cleavage site; R is any 
purine) (Mount, 1982). The percentage of occurrence of each base at each 
Mammalian I Exon 1 AGj GURAGU ---YNYURAC--YAGI Exon 2 l 
yeast I Exon 1 AGjGUAUGU --- UACUAAC--CAGI Exon 2 I 
Figure 2. The conserved sequences at the 5' and 3' ss of 
mammalian and yeast pre-mRNA. A is any purine. Y is any 




position is A64G73JG100u100Aa2A68G84u63 (Mount, 1982). Mutations at the 
almost invariant GU dinucleotide completely inactivate the 5' splice site. 
Mutations at other positions have variable effects. For example, mutations at 
intron positions 5 and 6 completely inactivate the splice site in adenovirous Ela 
pre-mRNA (Solnick, 1981). In contrast, these same mutations do not appear to 
inactivate the 5' splice site of the human 8-g,lobin IVS1 gene (Treisman et al., 
1983). Instead, they activate cryptic splice sites (Treisman et al., 1983). 
Stronger sequence conservation of the 5' splice site junction is seen in 
yeast. The hexanucleotide /GTAYGT (Y is any pyrimidine) is essentially 100% 
conserved (Langford and Gallwitz, 1983; Teem et al., 1984). The apparent 
difference in degree of conservation between mammals and yeast is reflected in 
the behavior of mutations that inactivate the 5' junction. The 5' splice site 
mutations seldom activate cryptic splice sites in yeast (as opposed to 
metazoans), but lead instead to accumulation of pre-mRNA (Gallwitz, 1982; 
Pikielny et al., 1983) or nonproductive, aberrant 5'splice site cleavage products 
(Parker & Guthrie, 1985). 
5. Conserved Sequences At The 3' Splice Sites 
At the 3' end of the intron, three conserved regions are present: branch 
site, pyrimidine tract, and 3' splice site (Mount, 1982; Santen & Spritz, 1985). 
The branch site consensus is YNYURAC in mammals and UACUAACA in yeast 
(N is any nucleotide, underlined A is the branch site residue). A pyrimidine tract 
(Yn) is more pronounced and conserved in mammals than in yeast (Reed, 
1989; Wieringa et al., 1984). The consensus at the 3' splice site is YAGI in 
7 
mammals and CAG/ in yeast (Aymond & Rosbash, 1992). Both the 31 splice site 
and pyrimidine tract are required for 31 splice site recognition during the second 
step of splicing (Vijayraghavan et al., 1986; Fouser & Friesen, 1987; Parker & 
Siliciano, 1993; Chanfreau et al., 1994). In yeast, the 31 splice site consensus 
Y AG is dispensable for the first step of splicing (Aymond & Rosbash, 1985). The 
5' splice site cleavage and lariat formation take place in vitro in the absence of 
the 3' splice site. In mammals, the CAG 31 consensus motif, required in the first 
step of splicing, seems to be related to the pyrimidine tract. CAG is required for 
5' splice site cleavage and lariat formation in the presence of a short pyrimidine 
stretch but is not required if the pyrimidine stretch is long (Reed, 1989). 
B. Dynamic RNA-RNA Interactions In the Spliceosome 
1. snRNAs 
snRNAs are abundant, small(< 300 nucleotides) RNA molecules with 
highly phylogenetically conserved sequences (Baserga & Steitz, 1993; Guthrie 
& Patterson, 1988). There are five major snRNAs involved in splicing, U1, U2, 
U4, US, U6 (for reviews see Steitz et al., 1988; Ruby & Abelson, 1991; Lamond, 
1991; Guthrie, 1991 ). All, except U6, are transcribed by RNA polymerase II and 
contain a 51 cap structure that is hypermethylated (2, 3, 7-trimethylguanosine) 
(Dahlberg & Lund, 1988). U6 is transcribed by RNA polymerase Ill and acquires 
a y-methylphosphate cap. All of the five snRNAs localize to the nucleoplasm. 
Their secondary structures are well conserved from yeast to man (Baserga & 
Steitz, 1993; Reddy & Busch, 1988). 
8 
snRNAs are complexed with a set of proteins to form ribonucleoprotein 
particles, snRNPs (for review see Guthrie, 1991). Some of the proteins are 
specific for individual snRNAs. Some are common to most snRNPs. Antisera 
from patients with the autoimmune disease systemic lupus erythematosus 
contain anti-Sm antibodies targeted against the Sm protein common to U 1, U2, 
U4, and U5 snRNPs (Lerner & Steitz, 1979). Isolation of these monoclonal 
antibodies has made possible the characterization of the structure and function 
of snRNPs. 
2. U1 snRNA-pre-mRNA Interaction 
The first evidence that snRNAs are involved in splicing was the observed 
sequence complementarity of the 5' end of U1 snRNA and the conserved 5' 
splice sites of pre-mRNA (Fig. 3) (Lerner et al., 1980; Rogers & Wall, 1980). This 
has been subsequently verified biochemically and genetically. U1 snRNA 
selectively binds to a pre-mRNA 5' splice site in vitro (Mount et al., 1983). 
lmmunoprecipitation of crude nuclear extracts demonstrates that U 1 snRNP is 
associated with the pre-mRNA 5' splice site. According to sedimentation 
analyses of ribonucleoprotein complexes from mammalian nuclei, at least half 
of the wild type U1 snRNPs are associated with the 30S subunit that packages 
the high-molecular-weight precursors of pre-mRNAs. In addition, the absence of 
a short region of U1 snRNA complementary to 5' splice sites prevents the 
association of U1 snRNP with the 30S particles (Lerner et al., 1980). An elegant 
genetic experiment demonstrated that introduction of a compensatory 
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I I I 
AGIGUAUGU ---
pre-mRNA 
Figure 3. Interactions at the 5' ss during the course of splicing. 
U 1 binds to the 5' ss at a very early step in spliceosome 
assembly. It becomes dissociated from the spliceosome. The 5' 
ss is recognized a second time and delivered to the catalytic 
center of the spliceosome by U6 snRNA. 
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Genetic suppression analysis (via compensatory mutagenesis) in the 
fission yeast Schizosaccharomyces pombes has suggested that U1 also 
interacts with the 3' splice site (Reich et al., 1992). This interaction provides an 
attractive means of juxtaposition of 5' and 3' splice junctions early in the 
spliceosome assembly. However, only the block to the first step of splicing is 
relieved by U1 compensatory mutations. Therefore the 3' splice site must be 
recognized by a different factor during the second step of splicing. 
Although interaction of U1 snRNA with 5' splice site is required for usage 
of the splice site, it is not sufficient to define the exact cleavage site (Seraphin et 
al., 1988;Siliciano & Guthrie, 1988; Serahin & Rosbash, 1990). For example, 
mutation of the highly conserved G at intron position 5 in yeast often leads to 
aberrant cleavages (Parker & guthrie, 1985); however, these aberrant cleavage 
reactions are not prevented by compensating base changes in U 1 that restore 
base pairing between the mutant 5' splice site and U1 snRNA (Siliciano & 
guthrie, 1988; Seraphin et al., 1988). Mutations at intron position 1 (G to A) 
allow the step one of the reaction (Newman et al., 1985), yet further processing 
of the lariat intermediate is blocked. This blockage is not relieved by introducing 
the compensatory base change into U1 snRNA (Siliciano & Guthrie, 1988). 
These results suggest that the 5' splice site may be under suNeillance by other 
factors after their initial recognition by U1. It is now clear that U1 acts at a very 
early step in spliceosome assembly, becomes dissociated from the 
spliceosome later on, and is not required for the actual catalytic events 
(Crispino & Sharp, 1995; Konforti et al., 1993; Konforti & Konarska, 1994). 
1 1 
3. U6 snRNA-pre-mRNA Interaction 
Compelling evidence demonstrates that the 5' splice site is recognized a 
second time during spliceosome assembly and may be delivered to the catalytic 
center of the spliceosome by U6 snRNA. Cross-linking experiments indicate 
close proximity of U6 with the 5' splice junction (Sontheimer & Steitz, 1993). An 
essential region of U6 snRNA forms base pairs with conserved nucleotides at 
the 5' splice junction (Fig. 3) · (Kandels-Lewis & Seraph in, 1993). The functional 
interaction of the phylogenetically invariant ACAGAG sequence in U6 snRNA 
with the 5' splice site has been proven by genetic suppression (Kandels-Lewis 
& Seraphin, 1993; Lesser & Guthrie, 1993). Compensatory mutations, predicted 
to stabilize the interaction, increase normal cleavage and suppress aberrant 
cleavage resulting from a mutation in the conserved G at yeast intron position 5. 
Interestingly, the invariant ACAGAG sequence is immediately adjacent to 
sequences in U6 that base pair with U2 snRNA (Fig. 6). This proximity allows 
alignment of the 5' splice site with the branch site and subsequent nucleophilic 
attack by the branch point residue (Madhani & Guthrie, 1994). 
An in vitro synthesized RNA oligo nucleotide, which contains a 
consensus 5' splice site, has been shown to specifically bind to the U4/U5/U6 
snRNA complex (Konforti & Konarska, 1994). Unlike the interaction with U1 
snRNA, this recognition seems to depend largely on interactions other than 
RNA-RNA base pairing. The 5' splice site-U4/U5/U6 snRNP complex is 
proposed to be an intermediate in spliceosome assembly. The intermediate 
appears after the 51 splice site-U1 snRNA base pairing is disrupted but before 
the U4-U5 interaction is destabilized. 
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4. U2 snRNA-pre-mRNA Interaction 
The essential role of the U2 snRNP in pre-mRNA splicing was 
established by demonstrating that extracts depleted of U2 snRNP were deficient 
in splicing. U2 snRNA interacts with the branch point consensus to form a short 
helix which bulges out the branch site A residue (Fig. 4) (Parker et al., 1987; 
Query et al., 1994; Wu & Manley, 1989; Zhuang & Weiner, 1989). Base pairing 
interaction between U2 snRNA and the branch point region has been 
substantiated by compensatory mutations in both yeast and mammals (Parker 
et al., 1987; Wu & Manley, 1989; Zhuang & Weiner, 1989). 
Binding of U2 snRNA to the branch point requires multiple protein factors 
(eg., U2AF, U1 snRNP) and ATP (Brosi et al., 1993; Ruskin et al., 1988; Zamore 
et al., 1992; Zamore & Green, 1989). A conformational change, mediated by 
helicase-like splicing factor(s), might be necessary for efficient assembly of U2 
snRNA into the spliceosome (Ruby et al., 1993). The question of how this might 
help the association of U2 with the pre-mRNA remains to be addressed. 
5. US snRNA-pre-mRNA Interaction 
US snRNA contains a highly conserved single-stranded loop sequence 
that includes the invariant nine nucleotide motif (Patterson & Guthrie, 1987). 
Specific mutations in this loop can have striking effects on the specificity of 
S'splice site cleavage in pre-mRNAs with mutations at intron position 1 (G to A) 
(Newman & Norman, 1991 ). They either activate new 5' splice sites in the 
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Figure 4. Interaction of the branch point region with U2 
snRNA. The branch site A residue is bulged out. 
US snRNA 
Figure S. US snRNA/pre-mRNA interaction. The invariant 
loop sequence of US can base pair with nucleotides in exon 
1 or the first two bases of exon 2. This interaction persists 
through both steps of splicing. US may serve to anchor the 
excised exon 1 after the first step of splicing and help allign 
the nucleophile for the second catalytic step. Site of 
nucleophilic attack on the 3' ss is shown as arrow. Adapted 
from Science 262.1978-1979. 
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intermediates to mRNA. This is achieved by the invariant US snRNA loop base 
pairing with nucleotides upstream of the cleavage site or with the first two bases 
of exon 2, respectively (Fig. S) (Newman & Norman, 1992). Cross-linking 
experiments suggest: (1) the contact between US and exon 1 persists through 
both steps of splicing and (2) the first residue of exon 2 becomes crosslinked to 
US after the first step of splicing (Sontheimer & Steitz, 1993). Taken together, 
these data strongly suggest that US snRNA serves to anchor the excised exon 1 
within the spliceosome following the first step of splicing and help align the 
nucleophile for the second catalytic step. 
6. U4·U6 Helix 
Base pairing between U4 and U6 is probably the best characterized 
intermolecular snRNA-snRNA interaction. The interaction is strongly supported 
by phylogenetic studies (Brow & Guthrie, 1988) and has been demonstrated in 
several experimental systems (Brow & Guthrie, 1988; Hashimoto & Steitz, 1984; 
Rinke et al., 198S). Some mutations in U6 snRNA cannot be complemented by 
compensatory mutations in U4 snRNA (Madhani et al., 1990; Vankan et al., 
1990). This is due to additional roles for U6 nucleotides. After U4/US/U6 enters 
the spliceosome as a tri-snRNP, the extensive base pairing between U4 and U6 
is disrupted and replaced with a U2-U6 intermolecular interaction (part of the 
catalytic core of the spliceosome) (Lamond et al., 1988; Yea~ & Un, 1991). U4 
then dissociates from the spliceosome and does not participate further in the 
splicing reaction (Yean & Lin, 1991). Thus, U4 snRNA functions to deliver U6 
and prevent undesired U6 catalysis until the appropriate time. 
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7. U2-U6 Helices 
U2/U6 sNRNAs are thought to comprise part of the catalytic core of the 
spliceosome (Madhani & Guthrie, 1994b; Nilsen, 1994). Several base-pairing 
interactions, helices la, lb, and II (Fig. 6), have been proposed between U2 and 
U6 snRNAs (Madhani & Guthrie, 1992; Weiner 1993, Sun & Manley, 1995). 
The U2-U6 helix I was originally identified in yeast {Madhani & Guthrie, 
1992). It is composed of helix la, a two nucleotide bulge, and helix lb. Helix I 
exhibits extraordinary phylogenetic conservation, not only of the secondary 
structure but also of primary RNA sequences. Biochemical analysis shows that 
the integrity of this helix is required for efficient splicing in vivo. Formation of 
U2-U6 helix 1 has been confirmed genetically in yeast by showing that 
mutations in one pairing partner can be suppressed by a compensatory base 
change in the other. However, incomplete suppression is almost never 
complete, especially for certain mutations in U6, suggests additional essential 
roles for U6 nucleotides. U6 is the most conserved snRNA in terms of size and 
primary sequences (Baserga & Steitz, 1993). The formation of helix I could 
bring together the invariant ACAGAG sequences in the central domain of U6 
with sequences in U2 that lie immediately upstream of the branch point (Fig. 6). 
The ACAGAG sequences, which are potential catalytic residues of U6, can then 
be closely juxtaposed with the branch point and 5' splice site, which in turn, is 
recognized by U6. This provides an attractive structural basis for the 
spliceosomal active site (Madhani & Guthrie, 1994b). 
Helix II was discovered through psoralen crosslinking experiments in 
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Figure 6. U2/U6 snRNA helices. Formation of helix la brings together 
the invariant ACAGAG sequences (shaded) in U6 with the consensus 
AUGAUG sequences (shaded) in U2 together. ACAGAG interacts with 
the 5' ss. AUGAUG interacts with the branch point. This would position 
the U2-U6 structure (putative catalytic core) near both the 5' ss and the 
branch point, therefore providing an attractive structural basis for the 
spliceosomal active site. 
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conserved in all eukaryotic species, although the primary sequences are not. 
Mutations disrupting the formation of helix II result in splicing defects in Hela 
cells (Detta & Weiner, 1991; Wu & Manley, 1991). In Hela cells, helix II has been 
directly demonstrated by allele specific suppression (Detta & Weiner, 1991; Wu 
& Manley, 1991 ). In contrast to the observations with its mammalian 
counterparts, helix II does not appear to be esssential for yeast (Madhani et al., 
1990; Madhani & Guthrie, 1994a). Deletion of almost all of the U6 or U2 
nucleotides proposed to form helix II results in only a slightly cold-sensitive 
phenotype. The discrepancy between yeast and mammals can be explained by 
functionally redundant U2-U6 interactions in yeast (Field & Friesen, 1996). 
C. Effect of Secondary Structure on Pre-mRNA Splicing 
1. In The Presence of Splice Site Sequestration 
Pre-mRNA secondary structure has a significant influence on splice site 
selection and splicing efficiency. A naturally occurring pre-mRNA secondary 
structure sequesters the proximal 3' splice site of the budding yeast 
Kluyveromyces lactis actin intron and is required for activation of the distal 
3' splice site (Deshler & Rossi, 1991 ). Regulation of the splicing of ribosomal 
protein RPL32 pre-mRNA in Saccharomyces cerevisiae, may depend on the 
formation of a stem-loop structure which includes the 5' splice site (Eng & 
Warner , 1991 ). Experimentally introduced hairpins, which sequester the 
5' splice site or branch point region, strongly inhibit splicing in yeast, both in 
vivo and in vitro (Yoshimatsu & Nagawa, 1989; Goguel et al., 1993). 
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The inhibitory effect of hairpins, which sequester the 5' splice site, has 
also been observed in the dicot plant Nicotiana plumbaginifolia (Goodall & 
Fillipowicz, 1991; Liu et al., 199S). In mammalian systems, secondary structure 
can strongly influence the selection of alternative splice sites, regulating 
formation of multiple mRNAs from the same transcript (Libri et al., 1991; Solnick 
1985; Watakabe et al., 1989). 
2. In The Absence of Splice Site Sequestration 
Few studies have examined the effect of secondary structures occuring in 
exons, in the absence of splice site sequestration, on splicing. Dominski & Kole 
(1994) have used antisense 2'-0-methyl oligoribonucleotides to block a number 
of sequences in human B-globin pre-mRNA. They demonstrated that at least 
2S nucleotides of B-globin exon 2 sequences are required for splicing. us 
snRNA is one of the snRNAs likely to be affected by secondary structure in exon 
2 adjacent to the 3' splice site. The conserved US snRNA loop sequence has 
been shown to base pair with exon sequences adjacent to S' and 3' splice sites 
(Newman & Norman, 1992; Wyatt et al., 1992; Sontheimer & Steitz, 1993; 
Newman et al., 199S). It is possible that single-stranded exon regions at S' and 
3' splice sites are required for the effective involvement of US snRNA. Cellular 
proteins that interact with the 3' splice site may also be displaced. Introduction 
of secondary structure close to a 3' splice site could sterically hinder the access 
of trans-acting proteins to the 3' splice site. Among these factors are Slu7 and 
Prp8, which have previously been shown to promote 3' splice site recognition in 
the yeast Saccharomyces cerevisiae (Frank & Guthrie, 1992; Umen & Guthrie, 
199Sa; Umen & Guthrie, 199Sb). 
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D. Identification of Splicing Factors in Yeast 
1. Why Yeast? 
Following the demonstration of yeast pre-mRNA splicing in the early 801s 
(Domdey et al., 1984; Newman et al., 1985; Lin et al., 1985), detailed analyses 
of transcripts in yeast showed the strikingly identical lariat intermediate both in 
vivo and in vitro. The 51 end of the intron is joined by a 2'-5' phosphodiester 
· bond to a site within the intron. These results argued that yeast and mammals 
share fundamental similarities in pre-mRNA splicing. Because of the ease of 
combining genetic and biochemical analyses, Saccharomyces cerevisiae has 
since become an invaluable source of information on pre-mRNA splicing. 
2. Isolation of rna (prp) Mutants 
The first splicing factors in yeast were initially isolated in a screen for 
temperature sensitive mutants defective in the synthesis of macromolecules 
(Hartwell, 1967). Several of these mutants (rna2 to ma11) were later shown to 
have defects in splicing and to accumulate pre-mRNAs in vivo (Woolford, 1989; 
Warner JR, 1987). They were subsequently renamed pre-RNA processing (prp) 
mutants. 
Additional PAP genes have been isolated in screens of new sets of 
. temperature-sensitive mutants defective in RNA splicing or as second-site 
suppressors of mutations in spliceosomal components (for reviews see Guthrie 
1991; Ruby & Abelson, 1991; Aymond & Rosbash, 1992). Unlike the prp2-prp 11 
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mutants, which accumulate pre-mRNA, some of the additional prp mutants 
have novel phenotypes. For example, some accumulate the lariat intermediate 
or the excised intron, indicating their role in late stages of splicing. At present, 
some 30 PAP proteins have been identified. 
Yeast PAP proteins affecting splicing can be separated into two classes: 
snRNPs or non-snRNA protein splicing factors (Guthrie, 1991). The snRNPs are 
sometimes referred to as integral proteins. They bind tightly to one or more 
species of snRNA and can be co-immunoprecipitated with snRNA(s). The 
non-snRNP proteins are loosely associated with snRNAs and sometimes 
appear to interact transiently with the spliceosome. 
E. Yeast Helicase-like Splicing Factors 
Many of the PAP genes have been cloned and sequenced (Guthrie 
1991; Moore et al., 1993; Ruby & Abelson, 1991; Aymond & Rosbash, 1992). 
Sequence analysis has identified an exciting group of yeast PAP genes that 
belong to a family of ATP-dependent RNA helicases (Ruby & Abelson, 1991; 
Fuller-Pace, 1994)). These proteins are mainly classified into three subgroups: 
DEAD, DEAH or DEXH-box proteins (according to the differences in the 
conserved protein motifs) (for reviews see Wassarmann & Steitz, 1991; Schmid 
& Linder, 1992). PRP2, PRP16, and PRP22 are DEAH-box proteins. PAPS and 
PAPS are DEAD-box proteins. The identiication of the splicing factors 
resembling RNA helicases helps to explain the question posed earlier (section 
1.A.3): why is ATP required in the splicing reaction? These putative PAP 




PRP5 acts before the two catalytic steps of the splicing reaction {Fig. 7). It 
interacts with three other yeast spliceosomal proteins {PRP9, PRP11 and 
PRP21) to promote U2 snRNP binding to pre-mRNA {Ruby et al., 1993; Wells & 
Manuel Ares, 1994). Functional interaction between U2 snRNA and PAPS, 
PRP9, PRP11 and PRP21 has been suggested by synthetic lethality {Wells & 
Manuel Ares, 1994). Many synthetic lethal U2 mutations lie in highly conserved 
or invariant RNA structures, suggesting that the conserved U2 elements are 
required for efficient cooperative function with PAPS, PRP9, PRP11 and PRP21. 
The stable binding of U2 snRNP to the spliceosome is dependent upon 
ATP (Konarska & Sharp, 1987; Cheng & Abelson, 1987). The helicase-like 
PAPS may mediate a conformational change that is required for the association 
of U2 snRNP with pre-mRNA. 
2. PRP28 
A cold-sensitive mutant, prp28, inhibits the first step of mRNA splicing 
(Strauss & Guthrie, 1991 ). The cold sensitivity is caused by a single mutation in 
a conserved helicase motif. Two pieces of genetic evidence suggest that PRP28 
is functionally associated with the U4/US/U6 snRNP (Strauss & Guthrie, 1991 ). 
First, double mutants containing conditional alleles of PRP28 and PRP24, a U6 
snRNA-binding protein, exhibit synthetic lethality. Second, a suppressor of 
prp28-1 is a mutant allele of PAPS {a US snRNA-binding protein). Since U4 and 
U6 are normally held together by extensive intermolecular base pairs (Brow & 
Figure 7. The roles of five yeast 
PRP proteins in pre-mRNA 
splicing. Open box, exon 1; black 
box, exon 2; thin line, intron. 
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Guthrie, 1988; Hashimoto & Steitz, 1984; Rinke et al., 1985), dissociation of 
U4from the spliceosome and subsequent U2-U6 base pairing is likely to be 
energy-dependent and require the action of an ATP-dependent RNA helicase. 
3. PRP2 
PRP2 interacts transiently with spliceosomal complexes prior to and 
during step one of the splicing reaction (King & Beggs, 1990). 
lmmunoprecipitation established that PRP2 co-precipitated with pre-mRNA and 
splicing intermediates, but not with the spliced products. 
PRP2 is required for the first catalytic step of the splicing reaction (Lin et 
al., 1987). ATP hydrolysis is required at this step (Kim & Lin, 1993).The purified 
PRP2 protein has been demonstrated to have an RNA-dependent NTPase in 
vitro (Kim et al., 1992). PRP2 is postulated to bind to the spliceosome, hydrolyze 
ATP, induce a conformational change within the spliceosome, and allow 
splicing to proceed. 
4. PRP16 
PRP 16was first identified from a dominant mutant, prp16-1, that 
suppresses the deficiency of splicing of a mutant gene containing a branchpoint 
muation (A to C) (Couto et al., 1987). The prp16-1 allele contains a single 
nucleotide change near the conserved ATP-binding motif (Burgess et al., 1990). 
Additional prp16 alleles suppressing the branchpoint mutation were 
subsequently identified and all the suppressor mutations map near or within the 
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ATP-binding motif (Burgess & Guthrie, 1993). Not surprisingly, all suppressor 
mutations reduce ATPase activity in vitro (Schwer & Guthrie, 1992; Burgess & 
Guthrie, 1993). In vivo RNA analysis indicates that prp16 suppressor alleles 
increase the steady-state level of lariat intermediates (Burgess & Guthrie, 1993). 
These lariat intermediates that would otherwise have been degraded can be 
utilized. A model has been proposed in which decreased ATPase activity is 
coupled to a relaxation in fidelity (Burgess & Guthrie, 1993). ATP hydrolysis 
activates a discard pathway. Slowing the rate of ATP hydrolysis allows incorrect 
. intermediates more time to proceed through the productive splicing pathway 
and results in decreased fidelity. 
PRP 16 is required for step two of the splicing reaction in vitro (Schwer & 
Guthrie, 1991 ). PRP16 is a non-snRNP protein that associates tightly with the 
spliceosomes that have completed 5' splice site cleavage and lariat formation. It 
then hydrolyses ATP and releases itself from the spliceosome (Schwer & 
Guthrie, 1991). Stalled spliceosomes, pre-formed in a PRP16 immunodepleted 
extract, can be complemented with the purified PRP16 protein and ATP to yield 
mature mRNA (Schwer & Guthrie, 1991). The binding site of PRP16 in the 
spliceosome may be the 3' splice site (Umen & Guthrie, 1995a; Umen & 
Guthrie, 1995b). PRP16 is thought to have two possible functions: (1) bringing a 
potential 3' splice site into the spliceosomal active site or (2) mediating a 
conformational change that is required for the second step of splicing. 
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5. PRP22 
The PRP22 gene is not essential for either spliceosome assembly or 
both steps of splicing (Company et al., 1991 ). However, it is required for the 
release of the mRNA product from spliceosomes (Company et al., 1991 ). Heat 
inactivated splicing extracts prepared form prp22 mutants retain both mature, 
spliced mRNA, and excised lariat intron in the spliceosome. The first human 
RNA helicase-like splicing factor, HRH1, which is highly homologous to PRP22, 
has been identified (Ohno et al., 1994). Expression of HRH1 in a yeast prp22 
mutant partially rescues the temperature-sensitive phenotype. A dominant-
negative HRH1 protein stalls on the spliceosome and prevents release of the 
spliced RNA from the spliceosome. 
F. ATP-Dependent RNA Helicases 
1. Conserved Elements 
All of the putative RNA helicases show a considerable degree of amino 
acid sequence homology. The core region of about 380 amino acids contains 
several domains of conserved peptide sequence and relative spacing (Fig. 8) 
(Gorbalenya et al., 1988, Gorbalenya et al., 1989). The most characteristic 
sequence element of putative RNA helicases is the ATP-binding domain. The 
conserved sequence AXXGXGKT has been previously described as the A motif 
of ATPases (Saraste et al., 1990; Walker et al., 1982). The B motif of ATPases 
contains a DE sequence which is highly conserved and almost invariant in 
DEAD ~AXXGXGKTI 
DEAH ---iAXXGXGKT I 
DEXH -iAXXGXGKTI 
Suggested 
functions ATP binding 
I DEAD H SAT I 
I DEAH H SAT I . 









Figure 8. Schematic of the highly conserved motifs in putative RNA 
helicases. Depending upon the two amino acids following DE, putative 
RNA helicases are subgrouped into DEAD, DEAH or DEXH proteins. 
Adapted from Fuller-Pace, 1994. 
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putative RNA helicases (Walker et al., 1982). Depending upon the two amino 
acids following DE, putative RNA helicases are subgrouped into DEAD, DEAH 
or DEXH proteins (Fuller-Pace, 1994; Schmid & Linder, 1992). The motifs SAT 
and GRAGR are also conserved within the family of ATP-dependent RNA 
helicases (Gorbalenya et al., 1988 & Gorbalenya et al., 1989). The central core 
region is usually flanked by amino- and carboxyl-terminal residues of unique 
sequence which are thought to provide specifity to the functions of individual 
helicases. 
2. The Function of The Conserved Motifs 
Understanding the roles of the conserved motifs in putative RNA 
helicases has been greatly facilitated through extensive mutational analyses. 
Dominant mutations of prp16 alleles that suppress the mutated branch site all 
map to the ATPase domain and cause reduced ATPase activity in vitro (Schwer 
& Guthrie, 1992; Burgess & Guthrie, 1993). A systemic study of elF-4A shows 
that GXGKT motif is required for ATP binding and consequently ATP hydrolysis 
and RNA unwinding (Pause & Sonenberg, 1992). The DEAD motif in elF-4A is 
critical for ATP hydrolysis and consequently for RNA helicase activity, but not for 
ATP binding (Pause & Sonenberg, 1992). The SAT motif in elF-4A is 
dispensable for ATP binding and hydrolysis but essential for RNA helicase 
activity (Pause & Sonenberg, 1992). Mutations in the HRIGRXXR sequence 
drastically reduce elF4A cross-linking to RNA and abrogate RNA helicase 
activity (Pause et al., 1993). Some of those mutations also affect ATP binding 
and ATPase activity, suggesting a coupling of ATP hydrolysis and RNA 
unwinding. 
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3. Diverse Array of Cellular Functions Involved 
Many proteins have been identified in the family of putative 
ATP-dependent RNA helicases. They are isolated from organisms ranging from 
bacteria (E. coli) to man (H. sapiens) ( for review see Fuller-Pace, 1994; 
Schmid & Linder; 1992; Wassarman & Steitz; 1991). They are involved in 
multiple steps of RNA metabolism, which include RNA splicing, ribosome 
assembly, translation, initiation, RNA localization, RNA stability, 
spermatogenesis, embryogenesis, and cell growth and division. Five yeast PRP 
proteins, PrpS, 28, 2, 16, and 22, participate in pre-mRNA splicing (Schmid & 
Linder, 1992). Their identification has helped to decipher the highly dynamic 
and ATP-consuming process of splicing. The elF4A protein is believed to use 
the energy generated from ATP hydrolysis to unwind RNA secondary structure, 
to allowing the 40S ribosomal initiation complex to bind and scan for the 
initiation AUG codon (Abramson et al., 1987; Grifo et al., 1984; Linder et al., 
1989; Rozen et al., 1990). The SrmB and DeaD proteins from E.coli are 
thought to be required for ribosomal subunit assembly (Nishi etal., 1988; Toone 
et al., 1991 ). The Drosophila gene products Vasa and His are necessary for 
RNA localization in oogenesis (Lasko & Ashburner, 1988; Gillespie & Berg, 
1995). Recently, the DEAD/DEAH box RNA helicases have been implicated in 
RNA stability. Overexpression of the SrmB and Dead proteins has been shown 
to promote mRNA stability in E. coli (lost & Dreyfus, 1994). The Prp16 protein is 
proposed to control a discard pathway for aberrant lariat intermediates and the 
suppressor alleles of PRP16 were shown to stabilize lariat intermediates 
(Burgess & Guthrie, 1993). 
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4. Biochemical Activities 
Although putative RNA helicases have diverse cellular functions, there is 
one common theme among them. They are all thought to have similar 
biochemical activity and function through modulation of RNA structures 
(Fuller-Pace, 1994). Many of them have been demonstrated to possess an 
RNA-dependent ATPase activity (Fuller-Pace, 1994). Yet only a few (for 
example, elF-4A, p68 and Xenopus An3) exhibit an RNA helicase activity in 
vitro (Gururajan et al., 1994; Hirling et al., 1989; Rozen et al., 1990). This may· 
be due to specificity of the RNA substrate or the reaction condition. 
G. Objectives 
Numerous studies have focused upon the inhibition of splicing by 
hairpins (stem-loop structures) that sequester splice sites. Very few studies, 
however, have examined the inhibitory effect of secondary structures occurring 
in exons in the absence of splice site sequestration. We have inserted a 
cis-targeted hammerhead ribozyme encoding sequence, 5 nucleotides (nt) 
downstream of the actin 3' splice site in a yeast ACT-E. coli lacZfusion gene. It 
should be noted that the ribozyme does not cleave in yeast. We were simply 
utilizing the ability of the ribozyme sequence to form a stem-loop secondary 
structure. The ribozyme secondary structure occurs in exon 2 without 
sequestering the 3' splice site per se. The ribozyme sequence introduced in the 
pre-mRNA virtually abolishes splicing in vivo and inhibits expression of the 
ACT-/acZfusion protein in yeast. The mechanism by which the ribozyme 
impedes splicing was not known. Thus, we decided to isolate both cis - and 
trans -acting mutants that suppress this splicing blockage. 
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For the cis acting mutants, our goal was to identify the element that 
blocks normal pre-mRNA splicing. We sought to determine whether it is the 
primary sequence or secondary structure of the ribozyme which blocks splicing. 
If it is the secondary structure, then we sought to determine whether other RNA 
secondary structures in exon 2 also block splicing. Finally, we wished to 
determine whether the extent of splicing inhibition correlates with the stability of 
RNA secondary structure. 
For the trans acting mutants, our goal was to identify a protein factor 
involved in splicing. The spliceosome is a very complex machinery, with many 
identified proteins, and yet to be identified factors, participating in splicing. 
Identification of new splicing factors should help elucidate the complex process 
of pre-mRNA splicing. Our strategy for isolating a potentially new splicing factor 
was to look for mutations which suppressed the splicing blockage conferred by 
the hammerhead ribozyme 3' splice site to be used. An RNA helicase-like 
splicing factor with altered helicase specificity or higher than normal helicase 
activity was a possible candidate. Such a mutant helicase would be able to 
unwind the secondary structure of the hammerhead ribozyme, thereby allowing 
normal splicing of the pre-mRNA to take place. 
Achieving these goals has produced one published paper (Chapter 3) 
and several unpublished experiments which extend the paper's findings 
(Chapter 4). In addition, two additional strategies to identify HIV-1 RNA (CRS, 
INS-1, and TAR elements)-protein interactions required for HIV-1 gene 
expression are included in this dissertation (Chapter 6). When these strategies 
did not achieve their objectives, the project described above was initiated. 
CHAPTER 2 
MATERIALS AND METHODS 
A. Materials 
1. S. cerevisiae and E. coli strains 
J M43 (MAT a /eu2-3, 112 ura3-52 trp 1-289 his4-580) was kindly provided 
by Dr. Joan McEwen (Beckman Research Institute of City of Hope, Duarte, CA). 
It was used in the genetic screen for isolating cis- and trans-suppressors that 
could restore B-galactosidase expression. One of the two temperature sensitive 
trans-suppressors isolated was crossed with JM19 (MATa ade his4-580) (also 
kindly provided by Dr. Joan McEwen) and the resulting diploids were 
sporulated. A temperature sensitive haploid from this sporulation was 
backcrossed three times with JM43 to obtain JL2 (MAT trp1-289 ura3-52 
his4-580 rss 1-1 ). 
E. coli XL 1-Blue supE44 hsdR 17 (rk-, mk+) recA 1 endA 1 gyrA96re/A1 
lac- F' [ proAB+ /ac/q lacZ1M 15 Tn 1 O(tet r)] was used for propagating yeast 




2. Growth Media 
All yeast strains were grown in either YPD or CSM minus (CSM-) media. 
YPD liquid medium contains 1 % yeast extract (w/v), 2% peptone (w/v), and 2% 
dextrose (w/v). CSM minus dropout liquid medium contains 0.17% YNB-AA/AS 
(w/v), 0.5% (NH4)2S04 (w/v), and 2% dextrose (w/v). Sporulation liquid 
medium contains 1 % potassium acetate (w/v), 0.1 % yeast extract (w/v), and 
0.05% dextrose (w/v). YPD, CSM-, and sporulation plates have 2% agar (w/v) 
added. E. coli strains were grown in LB media, which contained 1 % bacto 
trypton (w/v), 0.5% yeast extract (w/v), 0.5% NaCl (w/v), and 0.1 % dextrose 
(w/v). 
3. Enzymes 
Restriction enzymes were obtained from Boehringer Mannheim 
(Indianapolis, IN), New England Biolabs (Beverly, MA), and Promega Corp. 
(Madison, WI). T 4 DNA ligase was obtained from Boehringer Mannheim 
(Indianapolis, IN) and New England Biolabs (Beverly, MA). AMV reverse 
transcriptase was obtained from Promega Corp. (Madison, WI). Taq DNA 
polymerase was obtained from Perkin-Elmer Cetus (Norwalk, CN). Zymolyase 
1 OOT was obtained from Seikagoku Kogyo Co (Tokyo, Japan). Glusulase was 
obtained from Sigma Chemical Co. (St. Louis, MO). 
4. Chemicals 
[y-32P]ATP and [a-32P]dCTP were obtained from Amersham Life 
Science Inc. (Arlington Heights, IL). Unlabeled deoxynucleotides were 
obtained from Life Technologies Inc. (Gaithersburg, MD). All other chemicals 
were molecular biology grade and were obtained from Sigma Chemical Co. 
(St. Louis, MO) or Fisher Scientific Co. (Irvine, CA). 
5. Plasmid Constructs 
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The mutations in artificially constructed cis-acting mutants were created 
by polymerase chain reaction (PCR) amplification of the pJYH7-mrz DNA using 
primers that contained the desired nucleotide changes. The PCRs were 
conducted in a Perkin-Elmer/Cetus DNA thermal cycler (using the strandard 
reaction mixtures suggested by the manufacturer). A stepped-cycle program 
was used: 30 cycles of 1 min at 94°C, 1 min at 55°C, and 1 min at 72°C. The 
amplified PCR products were digested with Sal I, then ligated with Sal I 
linearized pJYH7 vector DNA. 
B. Methods 
1. Mutagenesis of Yeast Cells 
Mutagenesis of yeast cells was performed according to the method of 
Winston (1993). Five milliliters of overnight culture of Sacharomyces cerevisiae 
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strain JM43 transformed with plasmid pJYH7-mrz was grown at 30°C. The 
concentration of cells was adjusted to approximately 2 x 108 cells/ml (according 
to an estimate of cell number at 00600). Cells were pelleted in a 
microcentrifuge, the pellet resupended in 1 ml sterile water, and washed twice. 
After the second wash, the cells were resuspended in 1.5 ml sterile 0.1 M 
sodium phosphate buffer, pH 7.0. Next 0.7 ml cell suspension was added to 
1 ml 0.1 M sodium phosphate buffer in a 13 x 100-mm sterile polypropylene 
tube. EMS was added to 1 ml aliquots of cells (different amounts to determine 
the optimal concentration for mutagenesis: EMS treatment should cause about 
40% of the cells to be killed for optimal mutagenesis). Treated cell suspension 
(0.2 ml) was transfered to a tube containing 8 ml of sterile 5% sodium 
thiosulfate, to stop mutagenesis by inactivation of EMS. Mutagenized cells 
(0.1 ml) were plated on CSM minus uracil agar plates. As a control, 0.1 ml of 
nonmutagenized cells were also plated. The percentage of cells killed by EMS 
treatment was calculated. The level of EMS that resulted in about 40% killing 
(i.e. 60% survival) was used for mutagenesis. 
2. Tetrad Analysis 
Tetrad analysis was performed according to the method of Treco & 
Winston (1993). Diploids were constructed by mating strains of opposite mating 
types (a and a) on the surface of agar plates. Cells from freshly grown streaks 
of each haploid parent were mixed together on YPD agar plates that allow 
growth of both haploid strains. The mating was allowed to proceed for at least 
4 hours at 30°C. The mixtures were replica-plated onto CSM- agar plates that 
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select for the diploid genotype. The diploids cells were grown freshly on YPD 
agar media before being patched onto a sporulation plate. After 3-5 days at 
30°C, tetrads were visualized by a light microscopy of a suspension of yeast in 
a drop of water on a microscope slide. To prepare yeast tetrads for dissection, 
sporulated tetrads was suspended in 100 µI of diluted glusulase in a 1.5-ml 
m icrocentrifuge tube. The tube was vortexed vigorously and incubated at 37°C 
for 5-30 minutes. The glusulase treatment was considered complete when 
approximately half the tetrads showed disruption of their ascus walls. The four 
spores should remain associated, but more loosely than when initially 
examined. The wall of the ascus should be expanded and loosely associated 
with the spores. Sterile water (0.8 ml) was gently added, by slowly dripping it 
down the inside of tube. The tube was set on ice. Glusulase-treated spores 
were streaked in two parallel Hnes·across the surface of a YPD plate. The plate 
was inverted (with the lid off) under a dissecting microscope. Individual spores 
were then dissected from tetrads and placed in a row for further analysis. 
3. Yeast Transformation 
Yeast transformation was performed according to the methods of 
Hill et al., {1991 ). A single yeast colony was inoculated into 2-3 ml YPD broth 
and grown with aeration at 30°C overnight. The following morning, about 
100 µI of the overnight culture was inoculated into 1 O ml YPD broth. Cells were 
grown at 30°C with shaking until 00600 reached 0.5-0.7. Cells were then 
centrifuged at 3000g for 15 minutes at 4°C. The pellet was washed in 1ml of 
LiOAc solution (0.1 M LiOAc, 10 mM Tris HCI (pH 8.0), 1 mM EDTA]. The 
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suspension was centrifuged as before, then resuspended by adding 0.1 ml of 
LiOAc solution and gently shaken by hand. Yeast suspension (0.1 ml) was 
added to a 1.5 ml centrifuge tube containing 10 µI of transforming DNA. The 
contents were mixed gently then left at room temperature for 5 minutes. Next 
280 µI of PEG4000 solution (50% PEG4ooo in LiOAc solution) was added. The 
contents were mixed by inverting the tubes 4-6 times. The tube was placed at 
30°C for 45 minutes without shaking. Next 43 µI DMSO was added to creat an 
approximate 10% (v/v) DMSO solution in tube. The contents were mixed by 
inversion, then heat-shocked at 42°C for 5 minutes. For temperature sensitive 
yeast strains, the heat shock temperature was 37°C. Cells were then 
centrufuged at 12000g for 30 seconds and resuspended in 1 ml dH20. About 
200 µI of transformed cells were spread on CSM- media. 
4. Assaay for J3-galactosidase In Liquid Cultures 
The quantitative assay of J3-galactosidase activity in liquid yeast cultures 
was performed according to the method of Reynolds & Lundblad (1987). A 
single yeast colony containing the lacZ fusion protein was inoculated into 5 ml 
of CSM minus uracil medium and grown overnight at 30°C. Approximately 
50-100 µI of the overnight culture was inoculated into 5 ml CSM minus medium 
and grown until 00600 reached 0.5-0.8. The cells were centrifuged 5 minutes 
at 3000g in a tabletop centrifuge and the pellets were resuspended in Z buffer 
and placed on ice. The 00600 was determined for each sample. Three 
replicate reaction tubes were prepared for each sample: 100 µI cells with 900 µI 
Z buffer (60 mM Na2HP04, 40 mM NaH2P04, 10 mM KCI, 1 mM MgS04, 
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50 mM P-mercaptoethanol, pH 7.0). Thirty microliters of 0.1 % SOS and 50 µI 
chloroform were added to each tube and the mixtures were vortexed for 
15 seconds and equilibrated for 15 minutes in a 30°C incubator. Then 0.2 ml of 
4 mg/ml ONPG was added, the mixtures vortexed 5 seconds, and the tubes 
innoculated at room temperature. When a medium-yellow color had developed, 
the reaction was stoped by adding 0.5 ml of 1 M sodium carbonate. The 
reaction time was noted. The cells were transferred to the eppendorf tubes and 
microcentrifuged at 14,000g for 1 minutes. OD420 and 00550 of the 
supernatant was determined. The units of p-galactosidase were then 
calculated with the following equation: 
U= 1000 x[(OD420)-(1.75 xODsso)] 
(t) X (v) X (ODeoo) 
t = time of reaction (min) 
v = volume of culture used in assay (ml) 
00600 = cell density at the start of the assay 
00420 =combination of absorbance by ONPG and light scattering by 
cell debris 
00550 = light scattering by cell debris. 
5. Yeast p-galactosidase Colony Filter Assay 
Please refer to section 3.E.3. 
6. Yeast Genomic DNA Isolation 
Yeast genomic DNA was prepared according to the methods of Treco 
(1993). A single yeast colony was inoculated into 10 ml YPD medium in a 
50-ml sterile, disposable polypropylene tube. The culture was grown 
16 to 24 hours at 30°C in a shaking incubator (250 rpm). The tube was 
centrifuged 1 O minutes at 3000g in a swing-bucket tabletop centrifuge at 
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4°C. The pellet was resuspended in 0.5 ml of sorbitol solution (0.9 M sorbitol, 
0.1 M Tris.HCI pH 8.0, and 0.1 M EDTA). Ten microliters of 1.5 mg/ml 
zymolyase in sorbitol solution and 50 µI of 0.28 M ~-mercaptoethanol were 
added to the tube to prepare yeast spheroplasts. The tube was vortexed gently 
and then incubated 1 hour at 37°C in a shaking incubator (250 rpm). The cells 
were centrifuged (as above). The pellet of spheroplasts was resuspended in 
0.5 ml Tris/EDTA solution (50 mM Tris.HCI pH 8.0 and 20 mM EDTA) by 
pipetting up and down repeatedly. The suspension was transfered to a 1.5 ml 
microcentrifuge tube. Fifty microliters of 10% SOS was added and the tube was 
inverted several times to mix. The tube was incubated 20 minutes at 65°C. Two 
hundred microliters of 5M potassium acetate was added and the tube was 
inverted several times to mix. The tube was set on ice for at least 30 minutes 
and microcentrifuged 10 minutes at room temperature or 4°C. The supernatant 
was poored into a clean, labeled 1.5 ml microcentrifuge tube and approximate 
1 ml 100% ethanol was added. The tube was inverted repeatedly to mix and 
microcentrifuged 10 minutes at 4°C. The pellet was resuspended in 300 µI TE 
buffer (10 mM Tris.HCI and 1 mM EDTA). resuspension of DNA pellet can be 
hastened by incubating the tube at 65°C and periodically finger-flicking or 
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vortexing it very gently. Five microliters of 10 mg/ml RNase A was added and 
the tube was incubated 1 hour at 37°C. Half a milliliter of 100% isopropanol 
was added and the contents were mixed until the DNA precipitated. The tube 
was microcentrifuged for 10 minutes. The DNA pellet was resuspended in 
50 µI TE. 
7. Southern Hybridization of Yeast DNA 
Southern hybridization of yeast DNA was performed according to the 
methods of Treco (1993). Five micrograms of yeast genomic DNA was digested 
with BamHI, C/al, and Hino111 respectively. The digested DNA was 
electrophoresed in an 1% (w/v) agarose gel. The gel was soaked in 400 mM 
NaOH for 30 minutes at room temperature with gentle shaking to denature the 
DNA. The gel was placed on top of two layers Whatman papers and one layer 
of zetaprobe filter. The DNA was transferred from the gel to the zetaprobe filter 
using a BioRad vacume blotter. The filter was rinsed with 2 x SSC solution 
(0.3 M NaCl, 0.03 M Tris-Sodium Citrate) and air dried. The filter was placed in 
a hybridization tube. 1 O ml of Rapid Hybridization Buffer ( purchased from 
Amersham Life Science Inc., Arlington Heights, IL) was added and the tube was 
incubated 2 hours at 65°C. A ramdom primed labeled, denatured probe 
(prepared by using a random-prime label kit purchased from Amersham Life 
Science Inc., Arlington Heights, IL) was added to the tube and the mixture was 
incubated 2 hours at 65°C. The hybridization buffer was then removed from the 
hybridization tube and 2 x SSC, 0.1 % SDS was added to the filter. The filter 
was washed 20 minutes at room temperature. The filter was again washed 
twice in 1 x SSC, 0.1 % SOS 20 minutes at room temperature. The filter was 
exposed to Kodak film with an intensifying screen at -70°C for 16 hours. 
8. Northern Blot Analyses 
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Yeast total RNA was isolated as described in Chapter 2. Formaldehyde 
gel electrophoresis separated RNA for Northern blot analysis according to the 
method of Clouet d'Orval et al., (1986). Fifteen micrograms of total RNA were 
heated to 95°C for 2 min to denature the RNA. RNA samples were 
electrophoresed in a formaldehyde/agarose gel. The gel was rinsed for 
20 minutes each in two changes of 500 ml of 1 O x SSC to remove formaldehyde 
from gel. A 20 x 30 cm glass plate was placed over a tray filled with 500 ml of 
1 O x SSC. A piece of Whatman 3MM filter was wet with 1 O x SSC buffer and 
draped over the glass plate, with both ends hanging into the buffer (to act as 
wick). The gel was placed carefully upside down (i.e. sample well opening 
down) over wick. A Zetaprobe nitrocellulose (NC) filter was wet with H2o and 
placed on top of gel. All air bubbles were smoothed out. Two pieces of 
Whatman 3MM paper was wet with H20 and laid individually on top of the NC 
filter and smoothed. Layers of folded paper towels were stacked flat over 3MM 
paper and were covered with a 20 x 30 cm glass plate. A small weight was 
placed on top. The transfer of RNA from gel to NC filter by capillary action 
proceeded for at least 12 hours at room temperature. After transfer, paper towel 
stacks and paper sheets were removed. The filter was rinsed once with 
2 x SSC and subsequently air dried at room temperature for 30 minutes. The 
filter was then UV- crosslinked for 12 seconds before hybridization. The filter 
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was hybridized with a random-prime 32p labeled DNA probe (prepared by 
using a random-prime label kit obtained from Amersham Life Science Inc., 
Arlington Heights, IL) in the presence of rapid hybridization buffer (Amersham 
Life Science Inc., Arlington Heights, IL). The hybridization was at 42°C. The 
filter was subsequently washed in 2 x SSC at room temperature and 
autoradiographed. 
9. Determination of mRNA Decay Rates 
For determination of mRNA decay rates, cultures of cells were incubated 
with 100 ug/ml of 1, 10-phenanthroline (Santiago et al., 1986) during 
exponential growth. Immediately after addition of the drug, cells were shifted to 
the restrictive temperature for various lengths of time. Following various amount 
of time at the restrictive temperature, cells were harvested rapidly by a brief 
centrifugation (20 seconds at 1 O,OOOg) and cell pellets were frozen in dry ice. 
Total RNA was then isolated as described in section 3.E.4. 
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An experimentally introduced secondary structure in exon 2 adjacent to 
the 3' splice site of a yeast ACT-E coli /acZfusion gene abolishes splicing in 
vivo and inhibits B-galactosidase production. We have devised a genetic screen 
to isolate both cis and trans-acting mutants which restore B-galactosidase 
activity. Two cis-acting mutants potentially destabilize the stem in the region 
close to the 3' splice site. One trans-acting mutant designated rss1-1 partially 
restores B-galactosidase activity by b9th increasing the splicing efficiency and 
stabilizing the precursor and lariat intermediate. The trans-acting suppression 
activity of rss 1-1 is specific for a particular structure since another artificially 
introduced secondary structure, which also blocks splicing, is not suppressed 
by this mutant allele. We have cloned the gene encoding the trans-acting 
mutant protein. The RSS1 gene is located on Saccharomyces cerevisiae 
chromosome Vandis a single copy, essential gene. The predicted RSS1 
protein has marked similarity to members of the putative ATP-dependent RNA 
helicase family. At the nonpermissive temperature the rss1-1 mutant allele 
decreases the steady-state levels of several endogenous messenger RNAs and 
increases the ratio of pre-mRNA to mRNA of specific messages. RSS1 is likely 
to play an interesting role in RNA processing. 
B. Introduction 
Pre-mRNA splicing is a fundamental process in eukaryotic cells and can 
be regulated in a number of ways. One factor that has been invoked in splicing 
regulation is RNA secondary structure. In recent years, it has been 
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demonstrated that RNA secondary structure can affect splice site selection and 
splicing efficiency. We have previously reported that a naturally occurring 
pre-mRNA secondary structure sequesters the proximal 3' splice site of the 
budding yeast Kluyveromyces lactis actin intron and is required for activation of 
the distal 3' splice site (Deshler & Rossi, 1991 ). Eng and Warner showed that 
regulation of the splicing of the ribosomal protein RPL32 pre-mRNA in 
Saccharomyces cerevisiae, may depend on the formation of a stem-loop 
structure which includes the 5' splice site (Eng & Warner .. 1991 ). Experimentally 
introduced hairpins which sequester 5' splice site or branch point regions 
strongly inhibit splicing in yeast, both in vivo and in vitro (Yoshimatsu & 
Nagawa, 1989; Goguel et al., 1993). Inhibitory effect of hairpins with potential to 
sequester the 5' splice site have also been observed in the dicot plant Nicotiana 
plumbaginifolia (Goodall & Filipowicz, 1991; Liu et al., 1995). In mammalian 
systems, secondary structure can strongly influence the selection of alternative 
splice sites, regulating formation of multiple mRNAs from the same transcript 
(Clouet d'Orval et al., 1991; Libri et al., 1991; Solnick 1985; Watakabe et al., 
1989). 
We have observed that an artificially introduced stem-loop structure, 
formed by a mutant hammerhead ribozyme inserted 5 nucleotides downstream 
of the ACT 3' splice site in a yeast ACT-E. coli lacZ fusion gene, virtually 
abolishes splicing in vivo and inhibits expression of lacZ (Castanotto et al., in 
prep). To understand how splice site context, especially proximity to a 
secondary structure, can affect utilization of splice sites, we screened for 
cis- and trans-acting suppressor mutations that restored splicing, thereby 
allowing functional expression of the ACT-mrz-lacZ fusion message. We 
isolated four mutants, two cis-acting and two trans-acting, which partially 
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restored expression of the ACT-mrz-lacZ fusion gene. We have cloned the 
gene encoding the trans-acting mutant protein, designated RSS1 (RNA Stability 
and Splicing). RSS1 is located on S. cerevisiae chromosome V. The predicted 
RSS1 gene product has marked similarity to members of the DExH family of 
ATP-dependent RNA helicases. We report evidence here that RSS 1 is a novel 
protein involved in mRNA splicing and stability. Activation of the 3' splice site 
the cis-acting mutants is most probably a consequence of destabilization of a 
stem structure adjacent to the 3' splice signal. The rss1 mutant encodes a 
protein which recognizes the secondary structure in such a manner as to 
stabilize both the precursor and lariat intermediates. We speculate that this 
stabilization interaction is accompanied by a local unwinding of the stem, 
thereby allowing step 2 of the splicing reaction to take place. 
C. Results 
1. A Stem-Loop Structure Close to the 31 Splice Site 
Inhibits Both Steps of Yeast Pre-mRNA Splicing, 
Predominantly the Second Step 
A yeast ACT-E. coli lacZ fusion gene was constructed in which the 
promoter, exon 1 and intron sequences of the yeast ACT gene were fused to the 
E. coli lacZ gene. B-galactosidase expression is dependent on splicing of the 
yeast ACT intron (Deshler & Rossi, 1991 ). We have observed that a cis-acting 
mutant hammerhead ribozyme, inserted 5 nucleotides downstream of the ACT 
3' splice site in exon 2 of the yeast ACT-E. coli lacZ fusion gene, virtually 
abolishes splicing in vivo and inhibits B-galactosidase expression. Even 
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reverse transcriptase initiated PCR (RT-PCR) analysis did not reveal spliced 
transcripts. This inhibition is observed regardless of whether the ribozyme is 
active or inactive (mutant ribozyme), or inserted in a sense or antisense 
orientation (Castanotto et al., in prep). Approximately 0.02 units of 
B-galactosidase were produced from pJYH7-mrz, compared to 350 
B-galactosidase units from the parental vector pJYH7 (Fig. 9A). Yeast colonies 
harboring the vector pJYH7-mrz are white upon X-gal colony filter assay, 
whereas yeast colonies harboring pJYH7 are blue (Fig. 9A). 
To determine which step of the splicing reaction the stem-loop structure 
impedes, we carried out primer extension analyses of RNAs using a primer (ivs) 
that hybridizes to the intron region upstream of the branch point (Fig. 98). If 
annealed and extended, the ivs primer will generate a 170-nt cDNA product 
corresponding to the pre-mRNA, as well as a 68-nt product corresponding to the 
lariat intermediate or excised intron-lariat. As shown in Fig. 98, primer extension 
of RNA extracted from JM43 cells transformed with pJYH7 showned no 
detectable products corresponding to pre-mRNA or lariat intermediate, 
suggesting efficient splicing of the yeast ACT-E. coli /acZ fusion gene. In 
contrast, primer extension analyses of RNA extracted from JM43 cells 
transformed with pJYH7-mrz resulted in a marked accumulation of pre-mRNA 
and lariat intermediate (Fig. 98). Although the ivs primer could not differentiate 
between lariat intermediate and excised intron-lariat, we believe the observed 
68-nt cDNA product is derived solely from lariat intermediate since excised 
intron-lariat was not even detectable from pJYH7 carrying the efficiently spliced 
ACT intron. These data demonstrate that the stem-loop structure close to the 
3' splice site represses the utilization of both step 1 and 2 of splicing, but 
primarily step 2. 
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Figure 9. A: Schematic representation of the S. cerevisiae ACT-E. coli lacZ 
fusion gene in plasmid pJYH7 and the ACT-mrz-/acZ fusion gene in plasmid 
pJYH7-mrz. A mutant ribozyme (see Fig. 28 for sequence and secondary 
structure) was cloned 5 nucleotides downstream of ACT 3' splice site and in 
the lacZ reading frame. B-Galactosidase activities derived from these are 
indicated (a: units of B-galactosidase activity in this paper were determined as 
an average value of three independent measurements unless otherwise 
stated.) 
B: Primer extension analyses of total RNA prepared from S. cerevisiae JM43 
cells transformed with pJYH7 or pJYH7-mrz. The ivs primer complementary to 
the intron region upstream of the branch point of the ACT-mrz-/ac Z fusion 
transcripts is indicated by a black dot. The primer extension products are· 
shown schematically beside the autoradiograph by wavy lines. The products 
corresponding to pre-mRNA and lariat intermediate were normalized to U6 
snRNA to ensure that equivalent amounts of total RNA were used for primer 
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2. A Genetic Screen Scheme for Identification of Cis- and 
Trans-Acting Suppressors Which Restore B-Galactosidase 
Expression 
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In order to better understand how splice site context, especially proximity 
to a secondary structure can affect splice site utilization, we devised a genetic 
screen to isolate both intragenic (cis) and extragenic (trans) suppressors of 
pJYH7-mrz that could restore B-galactosidase expression (Fig. 10). 
S. cerevisiae JM43 strain cells harboring pJYH7-mrz were chemically 
mutagenized with ethyl methanesulfonate (EMS) and plated on CSM (minus 
uracil) medium at 23 °C to select for transformants. To identify mutants, B-gal 
yeast colony filter assays were performed. Colonies that expressed 
B-galactosidase (blue upon X-Gal staining) were identified and purified. To 
determine whether restoration of B-galactosidase expression was due to a 
plasmid borne or chromosomal mutation, plasmid DNAs were cured from yeast 
cells by growing them under nonselective conditions. Unmutagenized 
pJYH7-mrz plasmid DNAs were then transformed into the cured cells and B-gal 
yeast colony filter assays were performed. Colonies with restored B-gal 
expression harbored trans-acting suppressors; colonies that were B-gal 
negative had previously contained cis-acting, plasm id borne suppressors. 
Using this strategy, we have isolated two cis- and two trans-acting suppressors. 
S. cerevisiae transformants harboring pJYH7-mrz 
I mutagenized with EMS l 
• I plated on CSM (-1Jracil) plates I 









identify blue colonies, cure plasmid DNAs, 
tsf w/ unmutagenized pJYH7-mrz plasmid DNA, 
perform P-gal yeast colony filter assay 
White 
cis-acting mutant(s) 
Still Blue · 
trans-acting mutant(s) 
Figure 10. Strategy to isolate cis - and trans-acting mutants that 
alleviate the splicing blockage exerted by the hammerhead ribozyme 
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3. Cis-Acting Suppressors Potentially Destabilize the Stem of 
the Mutant Ribozyme in Proximity to the 3' Splice Site 
The two cis-acting suppressors isolated allow partial restoration of 
B-galactosidase expression. About 1.3 and 4 units of B-galactosidase activities 
were observed in cis-mutant 31 and 38 respectively (Fig. 11A). Sequencing of 
the entire ACT intron and adjacent exon sequences including the mutant 
ribozyme revealed that the mutants had single base alterations in the ten base 
pair stem Ill of the mutant ribozyme construct (Fig. 118). Mutant 31 had a single 
G to A transition and mutant 38 a G to T transversion. Both mutations potentially 
destabilize base pairing in the stem, suggesting that the stem close to the splice 
site played a pivotal role in inhibition of splicing and that local breathing of the 
stem could lead to reutilization of the splice site. 
4. The Trans-Acting Suppressor is Temperature Sensitive 
Out of -100,000 EMS mutagenized pJYH7-mrz transformed yeast cells 
sc.reened, two independent trans-acting suppressors were recovered. About 
13 units of B-galactosidase activity were produced from the pJYH7-mrz in both 
trans-mutants compared to 0.02 units of B-galactosidase activity in the parental 
JM43 strain. In addition to partial restoration of B-galactosidase expression, we 
also observed a temperature sensitive phenotype in both mutants. Tetrad 
analyses of one of the mutant isolates, JL2, showed that the temperature 
sensitive phenotype segregated 2:2 in more than 30 tetrads tested, suggesting 
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3'SS CAGCUGtCtGCCG AGUA GU CAGCCUGGG C 
U A 
(38) (31) 
Figure 11. A: B-Galactosidase activities of the two cis-acting mutants are 
indicated. B: Mutations recovered in cis-acting mutants that were 
responsible for partial restoration of B-galactosidase expression. Shown is 
another schematic representation of the ACT-mrz-lacZ fusion gene. The 
mutant hammerhead, cis-targeted ribozyme was inserted into a Sal I site 
(GTCGAC) 5 nucleotides downstream of ACT 3' splice site and has a 
potential to form stable stem-loop secondary structure in vivo. In the cis-
acting mutant 31, a single mutation was identified in stem Ill of the mutant 
ribozyme close to the 3' splice site, replacing a G with an A. In the cis-
acting mutant 38, another single mutation in the same stem replaced a G 
with a T. 
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sensitive phenotype and the ability to restore B-galactosidase activity were 
genetically linked, we transformed pJYH7-mrz into independently isolated 
colonies derived from 4 temperature sensitive spores and 4 temperature 
resistant spores and performed a yeast colony filter assay. All the temperature 
sensitive colonies became blue and the temperature resistant colonies 
remained white upon X-Gal staining. This suggests that the temperature 
sensitive phenotype and the suppressor phenotype cosegregated and were 
due to a single mutation. The temperature sensitive phenotype of JL2 was 
found to be recessive as judged by the growth at 37 °c of diploids formed by 
mating JL2 to a wild type strain. The suppressor phenotype was found to be 
dominant as judged by the increased B-galactosidase from ACT-mrz-lacZ in the 
heterozygous diploid. Complementation analyses showed that JL2 fell into a 
single complementation group with the other mutant isolate. JL2 was used for 
further characterization of the trans-acting mutations. 
5. The Trans-Acting Suppressor Restores B-Galactosidase 
Expression from ACT-mrz-/acZ by Both Increasing Pre-mRNA 
Stability and Enhancing Splicing Efficiency at the Permissive 
Temperature 
To understand how the JL2 mutant strain restored B-galactosidase 
expression from ACT-mrz-lacZ, primer extention analyses of RNAs extracted 
from the JL2 mutant and the wild type JM43 cells transformed with pJYH7-mrz 
were carried out {shown in Fig. 12). The ivs primer complementary to the intron 
region upstream of the branch point was used. The extended cDNA products 
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Figure 12. Primer extension analyses of RNAs. Total RNAs extracted from the 
wild type JM43 and the trans-acting mutant JL2 cells transformed with the 
pJYH7-mrz were subject to primer extension analyses using the ivs primer. The 
extended products were electrophoresed in a denaturing 6% polyacrylamide 
gel. Shown is an autoradiograph after a 24 hour exposure. The position of the 
ivs primer hybridization is indicated by a black dot. The primer extension. 
products are shown schematically beside the autoradiograph by wavy lines. 
The products corresponding to pre-mRNA and lariat intermediate were 
normalized to U6 snRNA. Quantitation was carried out using a Bio-Rad 
Phosphor Analyst/PC. 
55 
were quantitated and normalized to U6 snRNA. Relative to JM43, the JL2 
mutant allele increased the level of the ACT-mrz-/acZpre-mRNA 2-fold and the 
level of lariat intermediates 4-fold at the permissive temperature. The increased 
levels of pre-mRNA and lariat intermediate could be due to, a) up-regulated 
transcription, b) inhibition of splicing and/or c) increased RNA stability. Since 
the plamid-borne ACT-mrz-lacZ fusion gene utilized the same promoter as 
endogenous ACT1, we examined the effect of the mutant allele on the 
endogenous ACT1 transcript levels at the permissive temperature. Primer 
extension analyses using the ivs. primer to detect endogenous ACT1 
pre-mRNAs showed that the mutant allele had no discernible effect on 
endogenous ACT1 pre-mRNA levels at 23 °C (Fig. 13). Based upon these data, 
it is unlikely that the mutant allele up-regulates transcription. Inhibition of 
splicing alone cannot account for the higher amounts of pre-mRNA in the 
mutant background since that would decrease the mature B-galactosidase 
transcript levels and downregulate B-galactosidase expression. We therefore 
reason that the mutant JL2 increased the steady-state levels of ACT-mrz-lacZ 
pre-mRNA and lariat intermediate. 
To demonstrate mature ACT-mrz-lacZ mRNA levels, We performed 
quantitative RT-PCR analyses (Fig. 14). Reverse transcription and thirty cycles 
of PCR amplication of RNAs extracted from the JL2 mutant transformed with 
pJYH7-mrz gave rise to a DNA product corresponding to the spliced 
ACT-mrz-lacZ mRNA while the wild type JM43 did not. The amplified DNA 
product was purified form the gel, eluted, reamplified, sequenced and verified to 
be the spliced ACT-mrz-lacZ transcript. RT-PCR analyses of the ACT1 spliced 
product were carried out as an internal spliced RNA standard (Fig. 14). 
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Figure 13. Primer extension analyses of RNAs. Total RNA extracted from the 
wild type JM43 and the mutant JL2 cells (grown at 23 °C) were subject to primer 
extension analysis using the ivs primer. Since wild type ACT1 is efficiently 
spliced, we did not detect any ACT1 pre-mRNA in an autoradiograph after a 24 
hour exposure (data not shown). Shown here is an autoradiograph following an 
extented (one week) exposure. 
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Figure 14. RT-PCR analyses of mature ACT-mrz-/acZmRNA levels in the wild 
type JM43 versus the mutant JL2 cells. RNAs were extracted from the wild type 
JM43 and the trans-acting mutant JL2 cells transformed with the pJYH7-mrz. 
RT-PCR analyses were carried out as described in Materials and Methods. 
Endogenous ACT1 mRNA was used as an internal standard for relative 
quantitation of the ACT-mrz-lacZ mRNA RT-PCR products. 
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Taken together, the results of RNA analyses showed that the mutant JL2 
restored B-galactosidase expression from ACT-mrz-/acZ by both increasing 
pre-mRNA stability and enhancing splicing efficiency. 
We have compared the fold increase in B-galactosidase activity 
expressed from ACT-mrz-lacZ and ACT-L\IVS in the mutant cells. ACT- .!\IVS 
was constructed by a precise deletion of the intron in ACT-mrz-/acZ. As shown 
in Table 1, the mutant gave rise to 650-fold increase in B-galactosidase activity 
expressed from ACT-mrz-lacZ compared to only approximately 2-fold increase 
in B-galactosidase activity from ACT- .!\IVS. These data clearly indicate that the 
mutant acts in an intron-dependent fashion. 
6. The Trans-Acting Suppressor Activity is Specific for the 
Mutant Ribozyme Secondary Structure 
To address whether the trans-acting suppressor activity was specific for 
primary sequences or secondary structure of the mutant ribozyme, we replaced 
the mutant ribozyme with the antisense sequences of the ribozyme which also 
blocks 3' splice site utilization in JM43. With this construct, the trans-acting 
suppressor restored B-galactosidase production to a level similar to 
ACT-mrz-lacZ, suggesting that the suppressor recognizes secondary structure 
as opposed to a primary sequence. We have also tested the cis-acting mutants 
which have a secondary structure similar as the mutant ribozyme (Fig. 11 B) 
and found that the splicing of these transcripts was substantially increased 
(15 fold) in the context of the trans-acting suppressor (Table 2). 
Table 1. Fold increase in ~-galactosidase activity between mutant 
and wild-type cells. 
Construct 
ACT-m rz- lacZ 
ACT-AIVS 
Fold increase in 
~-gal activity ....... 
650 
2 
The mutant and wild type cells have been transformed with 
plasmids containing ACT-mrz-/acZ and ACT-AIVS (intron-less 
construct of ACT-mrz-/acZ) respectively. The ACT-mrz-/acZ 
construct displayed a 650 fold increase in ~-galactosidase activity 
when expressed in the mutant cells compared to wild type cells 
(13 units vs. 0.02 units respectively). The ACT-AIVS construct 
displayed approximately 2 fold increase in ~-galactosidase activity 
when expressed in the mutant cells compared to wild type-cells 
(122 ± 4 units vs. 51 ±1 units respectively). 
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Table 2. P-Galactosidase activity derived from the cis-mutant 31 









We next tested a secondary structure different from that of the mutant 
ribozyme. An 8-nucleotide hairpin was introduced into the yeast ACT-E. coli 
lacZ gene at the same site where the mutant ribozyme has been inserted, 
creating the ACT-SL-/acZ fusion gene (Fig. 15A). The plasmid pJYH7-SL 
containing the ACT-SL-/acZ fusion gene expressed 2-fold lower levels of 
13-galactosidase activity than pJYH7 in JM43, suggesting an inhibitory effect of 
the a-nucleotide hairpin on splicing. When pJYH7-SL was transformed into the 
mutant JL2 background, 13-galactosidase activity was even suppressed further 
(Fig. 158). This is in contrast with the 13-galactosidase activity restoration effect 
of the JL2 strain on pJYH7-mrz. Total RNA prepared from pJYH7-SL 
transformed JL2 and JM43 cells was prepared and used for primer extension 
analyses with the ivs primer (Fig. 15C). After quantitation and normalization to 
U6 snRNA, it was found that the mutant JL2 strain accumulated the 
ACT-SL-/acZ lariat intermediate by a factor of -2-fold over that observed in 
JM43. Concomitant with the increase in lariat intermediate, a decreased mature 
ACT-SL-/acZ mRNA level was observed in the mutant JL2 background by 
RT-PCR analyses (Fig. 150). These data showed that the trans-acting 
suppressor had the effect of inhibiting splicing to the ACT 3' splice site when the 
a-nucleotide stem-loop in exon 2 was present. This opposite effect of the 
trans-acting suppressor on 13-galactosidase expression from pJYH7-SL and 
pJYH7-mrz suggests that the mutant allele, herein refered to as rss1-1 (standing 
for RNA ~tability and ~plicing), interacts differently with the mutant ribozyme and 
the a-nucleotide hairpin. 
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Figure 15. A: Schematic representation of the ACT-SL-/acZ fusion gene. An 
a-nucleotide stem-loop was introduced into the yeast ACT-£. coli JacZ gene at 
the same site where the mutant ribozyme was inserted. B: B-Galactosidase 
activities derived from the plasmid pJYH7-SL containing the ACT-SL-/acZ 
fusion gene in the parental JM43 and the mutant JL2 cells. Values are given 
as means± SEM. n = 13 for both JM43 and JL2 cells. C: Total RNAs 
prepared from the parental JM43 and the mutant JL2 cells transformed with 
pJYH7-SL were subject to primer extension analyses using the ivs primer. 
D: Quantitave RT-PCR analyses of decreaced splicing efficiency of the 
ACT-SL-/acZ gene in the mutant JL2 cells as compared to the wild type 
JM43 cells. Quantitave RT-PCR analyses were carried out as described in 
Materials and Methods. Endogenous ACT1 mRNA was used as an internal 
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7. rss 1-1 Decreases the Steady-State Levels of Wild Type 
Messages at the Restrictive Temperature and Accumulates 
Pre-mRNA of Specific Message(s) in vivo 
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As described above, rss1-1 increases the stability of the ACT-mrz-lacZ 
fusion transcripts. It was thus reasonable to ask the question: Does rss1-1 affect 
the stability of wild type messages? To test this, we analyzed the steady-state 
levels of three wild type transcripts in the rss1-1 mutant strain. As shown by 
primer extension analyses (Fig. 16A), rss 1-1 did not alter the steady-state level 
of mature actin mRNA at the permissive temperature (23 °C). However, after a 
shift to 36 °C for 1 hour, the mutant allele resulted in a significant decrease of 
mature actin transcripts, compared with no detectable change in actin mRNA 
levels in JM43 at 36 °C. Northern blot analyses also demonstrated a reduction 
in mature mRNA levels of RP51A and CYH2 transcripts (Fig. 168 and 16C). No 
accumulation of ACT1 and CYH2 pre-mRNAs and lariat intermediates was 
detected. However, Northern blot analyses of RP51A transcripts indicated slight 
accumulation of ribosomal protein 51A pre-mRNA transcripts at both the 
permissive and nonpermissive temperatures, although far less than in the 
prp2-1 mutant (Fig. 168). No accumulation of ACT1 or CYH2 pre-mRNAs were 
observed (Fig. 168 & 16C). 
8. Cloning of the R 551 Gene 
The wild type RSS1 gene was cloned by complementation of the 
temperature sensitive phenotype of the rss1-1 mutant allele. A YCp50-yeast 
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Figure 16. A: Primer extension analyses of actin mRNA using a 32p end-
labeled pet23 primer that hybridized to exon 2 of the actin gene. Total RNA 
was extracted from the wild type and the rss1 mutant cells grown at 23 QC and 
after a 2 hour shift to 36 QC. The cDNA products were normalized to U6 
snRNA. B: Northern blot analyses of RP51A mRNA. Total RNA was extracted 
from the prp2-1, the wild type JM43, the rss1-1 mutant cells grown at 23 QC 
and after a 1 hour shift to 36 QC. 15 µg of the total RNAs were loaded on a 
1 % formaldehyde agarose gel. Following electrophoresis and blotting, the 
RNAs were hybridized to 32p end-labeled oligonucleotide probes 
complementary to RP51A. C: Northern blot analyses of CYH2 mRNA. Total 
RNA was extracted from the wild type JM43 and the rss1-1 mutant cells grown 
at 23 QC and after a 1 hour shift to 36 QC. 15 µg of the total RNAs were loaded 
on a 1 % formaldehyde agarose gel. Following electrophoresis and blotting, 
the RNAs were hybridized to a 32p end-labeled oligonucleotide probe 
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genomic DNA library was transformed into the rss1-1 temperature sensitive 
S. cerevisiae JL2 strain. Of -67,000 transformants screened, five 
complementing colonies were isolated. Plasmid DNAs from these cells were 
isolated and reintroduced into JL2. In all cases, plasmid DNAs conferred 
temperature resistance at 37 °C. The five plasmid DNAs contained the same 
11 kb yeast genomic insert defined by restriction enzyme digestion patterns. 
Subcloning narrowed the complementation activity to a 7. 7kb Sac l-Sau3A 
fragment (Fig. 17). 
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Genetic evidence that the complementing clone harbored the wild type 
RSS 1 allele rather than an extragenic suppressor was provided by targeted 
integration of the cloned sequence into the chromosomal region genetically 
linked to the original rss1-1 mutation (Fig. 18). A Sac I-Hind Ill fragment which 
contained the 5' end of the RSS1 ORF was subcloned into an integrating vector 
pRS305 (Sikorski & Hieter, 1989). The resulting plasmid pRS305-3ASH, 
contained both the LEU2 gene and the 5' end of the RSS1 ORF. This vector 
was linearized at a unique Bam HI site and transformed into a leu2, rss 1-1 
strain resulting in LEU+, temperature sensitive transformants. One of the stable 
LEU+, temperature sensitive transformants was then crossed with a leu2 RSS1 
strain. The resulting diploid was sporulated and 30 tetrads were analyzed. 
Cosegregation of the temperature sensitivity and LEU2 and of temperature 
resistance and leu2 in each tetrad was observed, verifying that the integration 
had occured at the RSS1 locus, and that the cloned gene was indeed RSS1. 
-· -------------------- --- -
Sau 3A Sal I San BI Hind ID Cla. I Sac I Sau3A 
. . ... 




Figure 17. Complementation analyses. The horizontal bars represent 
DNA fragments that were tested for their ability to complement the 
rss1-1 temperature sensitive defect. pLIN3A was the original RSS1 
isolate consisting of an 11-kb Sau 3A-Sau 3A insert cloned into the 
YCpSO Barn HI site. pLIN3A 1 consists of a 4.4-kb Cla I-Sau 3A fragment 
cloned into YCpSO. pLIN3A2 consists of a 6.2-kb Sac I-Sal I fragment 
cloned into pSEYC68. pLIN3A3 consists of a 7.8-kb Sau 3A-Sac I 
fragment cloned into YCpSO. 
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FIGURE 18. Genetic evidence that the complementing clone harbored the 
wild-type RSS1 allele rather than an extragenic suppressor. A. The 
integrating plasmid, PRS305-3ASH, containing LEU2 and 5' end of RSS1, 
was linearized at a .unique 8amH1 site and transformed into a leu2, rss1-1, 
strain. B. The resulting strain is Leu+ and ts-. C. This strain was then crossed 
with a leu2 RSS1 strain. The resulting diploid was sporulated and 30 tetrads 
were analyzed. Cosegregation of the temperature sensitivity (ts-) and LEU2 



















RSS1 leu2 RSS1 leu2 
72 
9. RSS1 is a Single Copy Gene and is Essential for Yeast 
Cell Viability 
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Southern hybridization of JM43 genomic DNA cut with several different 
restriction endonucleases and probed with a randomly primed labeled 
3.3kb Hind Ill-Sac I fragment gave only single bands of hybridization (data not 
shown). These data suggested that RSS1 is a single copy gene. 
In order to determine if RSS1 was essential for viability, we replaced one 
copy of the wild type RSS1 gene with a deletion-frameshift allele rss1::LEU2, in 
the diploid yeast strain JL4. As shown in Fig. 19, linearized pRS305-3AH3, 
containing the deletion-frameshift allelle and the LEU2 marker, was transformed 
into JL4, a diploid strain homozygous for the wild type RSS1 allele and for leu2. 
The resulting Leu+ transformants, presumably of the genotype RSS1rss1::Leu2, 
were sporulated and dissected. Only one or two spores were recovered from 
each tetrad. All of the viable spores were Leu· auxotrophs, indicating that the 
deletion-frameshift allele of RSS1 is lethal. This lethality of the rss1:: LEU2 null 
allele could be complemented by a plasmid borne, wild type allele of RSS1 
prior to sporulation(data not shown). These results demonstrated that the RSS1 
gene is essential. 
10. RSS1 Encodes a Putative ATP-Dependent RNA 
Helicase 
Comparison of a partial nucleotide sequence of RSS1 with GeneBank 
demonstrated that this sequence derives from S. cerevisiae chromosome V, the 
74 
Figure 19. RSS1 is essential for yeast cell viability. The integrating plasmid, 
PRS305-3AH3, containing the deletion-frameshift allele and the LEU2 marker, 
was linearized with BamH 1 and transformed into a diploid strain homozygous 
for the wild type RSS1 allele and leu2. The resulting Leu+ transformants were 
sporulated and dissected. Only one or two spores were recovered from each 
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entirety of which has been sequenced (Dietrich FS et al., unpublished data). A 
7.7kb Sau3A-Sac I fragment (Fig. 17), the smallest which complemented 
temperature sensitivity, contained a single ORF of 6,492-nucleotides. No 
consensus intron sequences were found, suggesting that the 6,492-nucleotide 
ORF is uninterrupted and could encode a protein of 2, 164 amino acids. The 
deduced amino acid sequence of RSS1 was compared with other known 
protein sequences in the non-redundant data base avai'lable at NCBI through 
the BLAST network server (Altschul et al., 1990). RSS1 is identical to a yeast 
hypothetical 264.2 KO protein and has a central domain of approximately 
357 amino acids that is similar to the superfamily of ATP-dependent DNA/RNA 
helicases (Fig. 20). The sequence of amino acids 521 to 528 contains an A 
motif characteristic of ATPases (Walker et al., 1982) which has been shown to 
be involved in ATP binding (Rozen et al., 1989). The DEIH sequence between 
amino acids 634-637 is a B motif of ATPases and is also thought to be required 
for ATP binding (Walker et al., 1982). The motifs SAT and GRAGR (positions 
671-673 and 873-877) are also conserved among the superfamily of 
ATP-dependent DNA/RNA helicases (Gorbalenya et al., 1988 & Gorbalenya et 
al., 1989). The function of these sequences is unknown, although it is 
postulated that they may be important for nucleic acid binding and helicase 
activity of these proteins (Gorbalenya et al., 1989; Linder et al., 1989; Pause et 
al, 1993). Not only does RSS1 possess conserved helicase motifs, these motifs 
are also at conserved positions (Gorbalenya et al., 1989). The 357-residue 
central domain, which is similar with ATP-dependent DNA/RNA helicases, is 
flanked by 520 amino-terminal residues and 1286 carboxyl-terminal residues of 
unique sequence. A second ATP-binding domain was found in the 











































Figure 20. Predicted amino acid sequence of the RSS1 gene. The six 




amino-terminus outside the central domain from amino acid positions 79 to 86. 
A blastp search also revealed that RSS1 shares a strong homology to yeast 
SK/2 and several other putative ATP-dependent RNA helicases (Dangel et al., 
1995 and Widner et al., 1993). Interestingly, SK/2 encodes an antiviral protien 
that blocks translation of L-A viral RNA. 
We also scanned the RSS1 protein sequences for the occurence of 
patterns stored in the PROSITE data base via the ExPASy molecular biology 
server. Interestingly, ScanProsite revealed the conserved ATP-binding motif as 
well as potential glycosylation sites, phosphorylation sites and a putative 
leucine zipper pattern. The putative leucine zipper (L-X6-L-X6-L-X6-L), which is 
present in many transcriptional regulatory proteins (Hoeffler et al., 1988; 
Landschulz et al., 1988; O'Shea et aL, 1989), is located in amino acid positions 
1073 to 1094 in RSS1. 
11. The Mutation in rss1-1 Which Confers the Suppressor 
and Temperature Phenotypes is 'Located Near a Conserved 
Helicase Motif That is Proposed for Nucleic Acids Binding 
To recover the rss1-1 mutant chromosomal allele for DNA sequence 
analysis, we used the gap repair method (Orr-Weaver er al., 1981 ). A gap was 
introduced into the centromere-based vector pLIN3A by removing a 3.5kb 
Sac 1-Sna Bl fragment (Fig. 21 ). The linearized DNA was then transformed into 
the JL2 mutant strain. Repair of the gap using chromosomal sequences as a 
template leads to an autonomously replicating plasmid that contains 
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Figure 21. Recovery of the rss1-1 mutation by the gap-repair 
method. A gap was introduced into the centromere-based vector, 
pLIN3A, by removing a 3.5-kb Sac 1-Sna Bl fragment. The resulting 
plasmid was then transformed into the JL2 mutant strain. The 
chromosomal rss1-1 allele was recovered by the plasmid, which 
was used as a template for gap repair). 
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phenotype indicating that the chromosomal mutations were contained within the 
gap. We sequenced the 3.Skb Sac 1-Sna Bl fragment and identified three 
mutations. One nucleotide change resulted in Pro to Leu substitution at position 
114, a second mutation changed Gly to Arg at position 858, which is near the 
conserved GRAGR motif proposed as a nucleic acid binding domain. The third 
change is a three base pair deletion eliminating an Asp codon at amino acid 
position 240. We weren't sure whether or not all three mutations were 
responsible for the suppressor or temperature sensitive phenotypes. We then 
recovered the chromosomal allele of the second trans-acting suppressor 
isolate. DNA sequence analysis revealed that it contained only a single point 
mutation, changing Gly to Arg at position 858. We therefore conclude that this 
mutation confers the suppressor and temperature phenotypes in rss 1-1. 
D. Discussion 
1. Secondary Structures Occuring in Exon 2 Adjacent to a 3' 
Splice Site Inhibit Yeast Pre-mRNA Splicing in vivo 
Pre-mRNA secondary structure has a significant influence on splice site 
selection. While numerous studies have focused upon the splicing inhibitory 
effect of hairpins which sequester splice sites, very few have examined the 
effect on splicing of secondary structures occuring in exons in the absence of 
splice site sequestration. In the current study, we have demonstrated that a 
stem-loop structure, formed by a mutant hammerhead, cis-targeted ribozyme 
inserted in exon 2 of a yeast ACT-E. coli lacZ fusion gene inhibits both steps of 
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the splicing reaction (Fig. 98). We have also observed the same inhibitory effect 
on splicing mediated by the antisense sequences of the mutant cis-targeted 
ribozyme (data not shown), indicating that the inhibition is due to secondary 
structure rather than a specific sequence. A different secondary structure, 
formed by an a-nucleotide hairpin, inserted in the same site as the mutant or 
antisense ribozyme, was also shown to partially inhibit splicing in vivo (Fig. 15). 
These data are consistent with the observations of Dominski & Kole (1994), 
who have used antisense 2'-0-methyl oligotibonucleotides to block a number of 
sequences in human B-globin pre-mRNA, and demonstrated that at least 25 
nucleotides of B-globin exon 2 sequences are required for splicing. Ours is the 
first demonstration of exon secondary structures in yeast which blocks splicing. 
One of the snRNAs likely to be affected by secondary structure in exon 2 
adjacent to the 3' splice site is U5 snRNA. The conserved U5 snRNA loop 
sequence has been shown to base pair with exon sequences adjacent to 5' and 
3' splice sites (Newman & Norman, 1992; Wyatt et al., 1992; Sontheimer & 
Steitz, 1993; Newman et al., 1995). It is possible that single-stranded exon 
regions at 5' and 3' splice sites are required for the effective involvement of U5 
snRNA. Cellular proteins that interact with the 3' splice site may also be 
displaced. Introduction of a strong secondary structure close to a 3' splice site 
could sterically hinder the access of trans-acting proteins to the 3' splice site. 
Among these factors are Slu7 and Prp8, which have previously been shown to 
promote 3' splice site recognition in the yeast Saccharomyces. cerevisiae 
(Frank & Guthrie, 1992; Umen & Guthrie, 1995a; Umen & Guthrie, 1995b). 
2. Isolation of Two Cis- and Two Trans-Acting Suppressors 
That Alleviate the Block to Splicing 
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To better understand the influence of pre-mRNA secondary structures on 
splice site selection, we have established a genetic screen to isolate cis- and 
trans-acting suppressors that restored splicing, thereby allowing expression of 
the ACT-mrz-/acZfusion gene. Two trans-acting suppressors were found to 
have the same mutation that is responsible for suppressor and temperature 
sensitive phenotype. Two cis-acting suppressors were isolated which were able 
to partially restore B-galactosidase activity (Fig. 11 A). Sequence data revealed 
that both had single mutations in stem Ill of the mutant ribozyme construct 
(Fig. 11 B): These mutations could destabilize stem Ill, thereby making 3' splice 
site available for recognition. These mutated stems could be further destabilized 
by a helicase activity. In supportive of this, a synergistic effect on 
B-galactosidase activity (Table 2) and splicing (not shown) was observed when 
the cis-mutations were coupled with the rss1-1 mutant allele. This sinergy 
suggests that the rss 1-1 mutant allele may be involved in distabilizing the stem 
Ill structure, thereby allowing selection of the 3' splice site. 
3. The Effects of the rss1-1 Allele on Expression of the 
ACT-mrz-/acZ, ACT-~IVS and ACT-SL-/acz Genes 
The rss1-1 allele increased the steady-state levels of ACT-mrz-/acZ 
splicing intermediates (pre-mRNA, lariat intermediate) and enhanced splicing 
efficiency at the permissive temperature (Fig. 12). The dramatic increase in 
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B-galactosidase activity driven from ACT-mrz-lacZ in contrast to that driven from 
ACT-~IVS, the intron-less version of ACT-mrz-/acZ, clearly indicates a 
splicing-dependent effect of rss1-1 {Table 1). The potential involvement in 
splicing of RSS1 is further implicated by rss1-1 decreasing the splicing 
efficiency of ACT-SL-/acZ. In vivo RNA analyses revealed an accumulation of 
lariat intermediates and a concomitant decrease of mature ACT-SL-/acZ mRNA 
(Fig. 15C and 150). 
Our results suggest that a preference of the rss1-1 allele has preference 
for some feature(s) of the secondary structure held in common between the 
mutant ribozyme and its antisense counterpart. That rss1-1 confers a unique 
suppressor phenotype led us to a gain-of-function model for this suppression. 
The suppressor mutation(s) may mediate a specific interaction with the mutant 
or antisense ribozyme secondary structure and thus stabilize the mutant 
ribozyme-containing transcripts, including the splicing intermediates. This 
stabilization along with a destabilization of stem Ill would result in increased 
spliced product formation. 
The specificity of the effect of rss1-1 on expression of the ACT-mrz-lacZ 
and ACT-SL-/acZ genes raises the intriguing possibility that the RNA 
recognition or binding may be coupled with the other functions of the RSS1 
protein. 
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4. The rss 1-1 Allele Decreases the Steady-State Levels of the 
Wild Type Messages and Creates a Splicing Defect of 
Specific lntron(s) at the Nonpermissive Temperature 
In an attempt to address the problem of why the trans-acting suppressor 
is temperature sensitive, we examined the RNA profiles of three wild type 
messages. Our experiments revealed a small but reproducibly detectable drop 
in the steady-state levels of ACT, RP51A and CYH2 mature mRNAs at the 
nonpermissive temperature (Fig. 16). The rss1-1 allele also increased RP51A 
pre-mRNA levels, although to a lesser extent than did prp2-1 (Fig. 168). No 
obvious accumulation of either actin or CYH2 pre-mRNAs was observed. This 
lack of a general splicing defect does not negate a general and essential role of 
RSS 1 in splicing. It is possible that the ASS 1 protein .is multifunctional and that 
the particular mutant allele we have isolated does not have a dramatic effect on 
splicing. The heterogeneous effects of rss1-1 on pre-mRNA splicing also raises 
the possibility that the protein may be involved in splicing of specific introns. The 
temperature sensitivity is likely to be the result of a global decrease in mature 
mRNAs, severe decrease in a subset of mRNAs, or the accumulation of 
pre-mRNA of a specific, essential message at the nonpermissive temperature, 
which we have not yet identified. 
In conclusion, we have examined the splicing inhibitory effect of an RNA 
secondary structure in exon 2 of an ACT-mrz-/acZfusion gene in yeast. We 
have isolated and characterized cis-mutations that partially relieve the 
secondary structure, thereby partially restoring splicing. We have also identified 
a trans-acting suppressor, rss 1-1. rss 1-1 partially restored expression of the 
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ACT-mrz-/acZfusion gene by both increasing the steady state levels of 
pre-mRNAs, lariat intermediates, and enhancing splicing efficiency. This 
suppressor activity seems to be specific for the mutant ribozyme secondary 
structure since another artificially introduced secondary structure, which also 
blocks splicing, is not suppressed by this mutant allele. We have cloned the 
wild-type RSS1 gene. It is a single copy, essential gene and encodes a putative 
ATP-dependent RNA helicase with a DEIH box. It is likely to play an interesting 
role in RNA processing. 
E. Materials and Methods 
1. 5. cerevisiae strains 
J M43 (MA Ta leu2-3, 112 ura3-52 trp 1-289 his4-580) (kindly provided by 
Joan McEwen) was used in the genetic screen for isolating cis- and trans-
suppressors that could restore B-galactosidase expression. One of the two 
temperature sensitive trans-suppressors isolated was crossed with JM19 (MA Ta 
ade his4-580) (also kindly provided by Joan McEwen) and the resulting 
diploids were sporulated. A temperature sensitive haploid from this sporulation 
was backcrossed three times with JM43 to obtain JL2 (MAT trpt-289 ura3-52 
his4-580 rss1-1). JL2 was transformed with a YCp50-yeast genomic DNA 
library and wild type RSS1 was identified. JL4 was homozygous for RSS1 and 
was derived from a cross between JL3 (MATa leu2-3, 112 ade his4-580 
trp1-289 RSS1) and JM43. An integrating vector pRS305-3AH3 (see plasmid 
construct) containg a deletion-frameshift allele of RSS1 and the LEU2 gene 
was linearized with Bgl II and transformed into JL4 to result in JL5 (MA Ta/a 
ade!Ade his4-580/his4-580 trp1-289/trp1-289 ura3-52/Ura rss1:Leu2/RSS1). 
Transformations of all yeast strains were performed using the 
DMSO-enhanced lithium acetate method (Hill et al., 1991 ). 
2. Plasmid constructs 
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The plasmid pJYH7 contained the ACT-lacZ gene fusion described 
previously by Deshler and Rossi, 1991. A mutant cis-targeted ribozyme 
(sequence shown in Fig. 28) was cloned into a Sal 1 site 5 nucleotides 
downstream of ACT 3' splice site to creat ACT-mrz-lacZ. ACT-AIVS was 
constructed by a precise deletion of the intron in ACT-mrz;./acZ A YCp50-yeast 
genomic DNA library provided by D. Ho and R.J. Lin was used to transform the 
RSS1 temperature sensitive JL2 strain. pLIN3A, the first isolated clone that 
complemented the temperature sensitive phenotype of JL2 contained a 11-kb 
Sau 3A yeast genomic fragment. A Sac I-Hind Ill fragment which contained the 
5' end of the RSS1 ORF was cloned into the yeast integration vector PRS305 
resulting in pRS305-3ASH. Targeted integration of pRS305-3ASH into the 
chromosome at the RSS1 locus was accomplished by digesting the plasmid 
DNA with Bam H1, followed by transformation into a temperature sensitive 
haploid strain and selection for Leu+ transformants. For creation of a 
deletion-frameshift allele of RSS1, pRS305-3ASH was digested with BamHI 
and treated with Mung Bean nuclease. The resulting plasmid pRS305-3AH3 
has a single base pair deletion (GGTACC'GTACC) as determined by DNA 
sequence analysis. 
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3. B·Galactosidase assays 
B-Galactosidase assays in liquid culture were performed as described 
previously (Reynolds & Lunkblad, 1987). B-Gal yeast colony filter assays were 
adapted from Breeden & Nasmyth (1985). Nitrocellulose filters (purchased from 
completely. The filters were lifted off the plates and submerged in liquid nitrogen 
for 20 seconds to permeabilize the yeast cells. The filters were then carefully 
removed from the liquid nitrogen, allowed to thaw with the colony side up for 
several minutes, and subsequently laid on Whatman 3MM chromatogtaphy 
paper soaked with 0.5mg/ml X-Gal in Z-buffer in a 100x15 mm polystyrene petri 
dish (Becton Dickinson). The filters were incubated from 30 minutes to 24 hours 
at 37 °c. 
4. Total yeast RNA extraction 
Total yeast RNA was extracted using a hot acid phenol procedure. 
Twenty ml yeast cultures were harvested and suspended in 1 ml of ice-cold 
50mM sodium acetate (pH 5.3), 10 mM EDTA. 0.1 ml of 10% SOS were then 
added and the cell suspension vortexed vigorously, followed by extraction with 
an equal volume of acid phenol (Appligene) at 65 °C for 1 min x 4. The mixtures 
were chilled in dry ice until phenol crystals appeared. After microcentrifugation, 
the aqueous phase was transfered to a new Eppendorf tube and a second hot 
phenol extraction was carried out. The aqueous phase was then extracted once 
with a 1: 1 mixture of phenol-chloroform at room temperature for 5 min, brought 
to 0.3 M sodium acetate (pH 5.3) and 2.5 vol of ethanol were added to 
precipitate the RNA 
5. Primer extension, Quantitative RT-PCR, Northern blot 
analyses 
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For primer extension analyses, 1 O µg of total yeast RNA were annealed 
with 0.5 pmol of 32p end-labeled oligo in 1 x reverse transcriptase (RT) (-Mg) 
buffer (0.05M Tris. Cl pH8.3, 0.06M NaCl and 0.01 M OTT). 2 ul of 36mM 
Mg(OAc)2 in 1 x RT (+Mg) buffer (0.006M Mg(OAc)2) were added to the 
annealing mixture which was then kept on ice. 10 units of reverse transcriptase 
in 1 x RT (+Mg) buffer were added to 3 µI annealing mixture and the reaction 
was incubated at 47 °C for 45 min. Samples were then subjected to 
electrophoresis in denaturing, 6% polyacrylamide gels. 
For quantitative RT-PCR analyses, reverse transcription steps were done 
as above (except that the oligoes were not 32p end-labeled). The PCRs were 
then carried out in a Perkin-Elmer/ Cetus DNA thermal cycler by using the 
standard reaction mixtures suggested by the manufacturer. A stepped cycle 
program was used. 10, 20 or 30 cycles of 1 min at 94°C, 1 min at 59°C and 
1 min at 72°C were carried out and it was maken sure that the amplified DNA 
products were not saturated. The DNA products derived were electrophoresed 
in an agarose gel, visualized by staining with ethidium bromide, quantitated and 
. normalized to ACT1 mRNA by IS-1000 Digital Imaging system (Alpha lnnotech 
Corporation). Northern blot analyses were performed as previously described 
(d'Orval et al., 1986). 
Quantification of ACT1, RP51A and ACT-mrz-lac Z mRNAs and primer 
extended cDNAs were accomplished by using a Bio-Rad Phosphor Analyst/PC. 
The quantitated products were normalized with U6 snRNA, expression of which 
is not affected by the rss1-1 mutant allele. 
CHAPTER 4 
ADDTIONAL STUDIES OF CIS· AND TRANS-ACTING MUTANTS 
AFFECTING 3' SPLICE SITE UTILIZATION 
The following unpublished studies include several additional 
experiments which extend the findings of Chapter 3. 
A. Phenotype of the Cis-acting Mutation (pCis-31) Can Be 
Suppressed By Restoring Base-Pair Complementarity Within the 
Ribozyme 
We have shown previously that an experimentally introduced secondary 
structure in exon 2 adjacent to the 3' splice site of a yeast ACT-E. coli lacZ 
fusion gene abolishes splicing in vivo thereby inhibiting p-galactosidase 
production (Lin & Rossi, 1996). Two cis-acting mutations that restored splicing, 
and consequently p-galactosidase production, were isolated. Sequence data 
suggest that both single mutations could disrupt base pairing in stem Ill of the 
ribozyme sequence (Fig. 3). To confirm this, we restored sequence 
complementarity and determined whether this suppressed the phenotype of the 
cis-acting mutation. We created a plasmid construct, p83, bearing both the G to 
A mutation in pCis-31 and a compensatory C to T mutation (Fig. 22). The 
mutations were created by polymerase chain reaction amplification of the 
respective DNAs using primers that contained the desired nucleotide changes. 
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5' -GUCGACCGCCGGC UCGGACC U 
3' -CAGCUGGCGGCCGAGUAAUCAGCCUGGG C 
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Figure 22. Phenotype of the cis-acting mutant (pCis-31) can be suppressed 
by restoring complementarity. Only the ribozyme RNAs encoded by the 
plasmids are shown. Plasmid pB3, bearing both the G to A mutation in 
pCis-31 and the compensatory C to U mutation, inhibits B-galactosidase 
expression. Plasmid p11, bearing only the C to U mutation, relieves the 
splicing blockage and partially restores B-galactosidase expression. The 
mutations in the hammerhead ribozyme are marked with * . 
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P-Galactosidase production from p83 was now inhibited as evidenced by a 
yeast p-galactosidase colony filter assay. To confirm that the compensatory C 
to T nucleotide change alone does not inhibit p-galactosidase production, we 
also created a plasmid construct, p11, bearing only the C to T mutation at the 
same site (Fig. 22). As expected, the compensatory C to T by itself does not 
cause inhibition of p-galactosidase production. Since the base pairing in stem 
Ill is disrupted in p11, the C to T mutation restored splicing and p-galactosidase 
production. 
B. A More General Phenomenon Of Exon 2 Secondary 
Structure-Specific Splicing Regulation 
To determine whether the cis-acting mutants isolated from our previous 
genetic screen (Lin & Rossi, 1996) represent a more general phenomenon of 
exon 2 secondary structure-specific splicing regulation, several other mutations 
were introduced into various sites within stem Ill of the ribozyme constructs 
(Fig.23). These mutations were created by polymerase chain reaction 
amplification of the respective DNAs using primers that contained the desired 
nucleotide changes. All of the mutations potentially disrupt base-pairing and 
increase the predicted AG of the secondary structures. The effects of these 
secondary structure-destabilizing-mutations on the splicing reaction were 
assayed using the yeast p-galactosidase colony filter assay. Our results 
(Fig. 23) indicate that they all allow reutilization of the nearby splice sites and 
increase p-galactosidase production. 
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Figure 23. The primary sequence and secondary structure of the artificially 
constructed cis-acting mutants. All of the mutations potentially disrupt base 
pairing and increase the predicted AG of the ribozyme. The mutations are 
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C. Identification and Characterization of a Third Cis-acting 
Suppressor, p18, from the Genetic Screen 
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We have now identified a third cis-acting suppressor, p18, from the 
genetic screen. p18 restored p-galactosidase activity to about 20 units, a level 
higher than the previous two cis mutants. We tried to sequence the region 
encoding the hammerhead ribozyme using automated ABI PRISM Dye 
Terminator Cycle Sequencing Kit (with AmpliTaq DNA Polymerase, FS). 
Surprisingly, the sequence could only be read 6-7nt into the ribozyme. It 
appears that the processivity of AmpliTaq DNA polymerase (FS) is inhibited. 
We determined whether the region could be amplified by PCR using Taq DNA 
polymerase. We tried a variety of different schemes, including initial denaturing 
at 94°C for 5-10 minutes, and increasing the annealing temperature to 72°C. 
We were unable to detect any PCR amplified product. 
We then tried to manually sequence the region encoding the ribozyme 
using Sequenase 2.0. Although GC compression was encountered, 
sequencing from both directions revealed a clear, overlapping primary 
sequence of the region. When folded, the region was able to form a 24-nt 
stem-loop secondary structure. However, when the reading frame was 
checked, we found a putative + 1 frameshift within the 24-nt stem-loop 
sequence. To examine whether there was a -1 frameshiftearly in the /acZgene 
so that lacZ reading frame would be restored, the 24-nt stem-loop sequence 
was deleted by digestion with Sal I (which flanks both ends of the 24-nt 
stem-loop sequence). The resultant plasmid was tested for its ability to express 
p-galactosidase. This plasmid expressed p-galactosidase activity, thereby 
ruling out the possibility that there was a -1 frameshift in the lacZ gene. 
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Additional experiments are underway to confirm the putative + 1 frameshift in the 
24-nt stem-loop sequence; and to explore the possibility of ribosome frameshift 
. as a result of the secondary structure of p18. 
The sequencing data indicates that p18 has a deletion of stem II and part 
of the catalytic core of the ribozyme (Fig. 24). The resulting region has the 
potential to form a 24-nt stem loop motif, with a LiG very similar to that of the 
hammerhead ribozyme. 
We have shown previously that the suppressor activity of rss 1-1 is 
specific for the secondary structure of hammerhead ribozyme. Since p18 
possesses a secondary structure much different from that of the hammerhead 
ribozyme, one predicts that suppressor activity would not be observed with p18. 
This was confirmed by transformation of p18 into wild-type S. cerevisiae strain 
JM43 and the mutant strain JL2. Comparison of the f3-galactosidase activities 
driven from these transformants indicated that the mutant rss1-1 strain does not 
up-regulate f3-galactosidase expression from p18. 
D. Attempts To Identify Protein Factors That Interact With The 
RSS1 Protein 
To further elucidate the essential cellular function of the RSS1 protein, 
we have attempted to identify genes encoding protein factors that interact with 
the RSS1 protein. We have taken two approaches, genetic and physical. 
We have isolated 25 naturally occuring revertants that can suppress the 
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5' -GUCGACCGCCGGCGAAAACACCGGGU U 
3' -CAGCUGGCGGCCGCUUUUGUGGUCCG C 
AG=-49.2 
Figure 24. The putative primary sequence and secondary structure of the 
ribozyme RNA encoded in plasmid p18. As shown here, p18 could result 
from pJYH7-mrz deletion of nucleotides encoding part of the ribozyme 
(ribonucleotides in the dashed triangle). 
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which are Ts+ Ade+ Ura-, were crossed with a RSS1 strain that was 
Ts+ Ade- Ura+. Tetrad analyses were then performed. If the revertants were 
intragenic suppressors, all four spores would be Ts+. If the revertants were 
extragenic suppressors (i.e. mutant interacting proteins), at least some of the 
spores would be ts-. Our results indicated that all 25 revertants were intragenic 
suppressors. 
A physical approach for identifying protein factor( s) that interact with 
RSS1 takes advantage of the yeast two hybrid system. In preparation for this, a 
1.5kb Pst1-Pst1 fragment of the RSS1 gene was cloned in frame with the yeast 
GAL4 DNA binding domain in pBTM116, resulting in pBTM3AP. Future 
experiments in the laboratory include screening a yeast GAL4 activation 
domain-genomic DNA library for genes encoding proteins that interact with the 
RSS1 protein. It is beyond the scope of this thesis to initiate the screening step 
and analyze the clones selected by the interaction between the GAL4 domains. 
E. rss 1-1 Does Not Affect The mRNA Stability Of Wild type 
Messages 
We have shown that the rss-1 allele decreases the steady-state levels of 
wild-type messages at the restrictive temperature. Our data support the 
interpretation that the decrease is due to inefficient splicing. We have also 
examined the possible role of rss1-1 in mRNA stability. We followed the decay 
rates of ACT1 and RP51A transcripts via Northern blot analyses following 
treatment of the cells with the transcriptional inhibitor 1, 10-phenanthroline. Our 
results did not suggest any dramatic difference between the decay rates in wild 
type JM43 cells and the ones in mutant JL2 cells (over a time period of 
90 minutes). These results further support an interpretation that rss1-1 
decreases the steady-state levels of wild type messages by lowering the 




A. Historical Perspective 
Obscure and unlikely connections can often lead to unexpected findings. 
In 1989, Dr. John Rossi initiated a project to develop anti-HIV-1 ribozymes. The 
objectives were to: (1) develop and employ a yeast (Saccharomyces 
cerevisiae) expression system in which ribozyme activity can be readily 
monitored via cleavage of a chimeric S. cerevisiae ACT-E. coli lacZ fusion 
mRNA; and (2) utilize the genetic attributes of the yeast (Saccharomyces 
cerevisiae) to identify critical variables leading to enhanced stability and 
catalytic activity of anti-HIV-1 ribozymes. During the course of the project, a 
splicing-related enigma was observed. The cis-acting hammerhead ribozyme, 
inserted 5-nt downstream of the ACT 31 splice site in the chimeric yeast 
ACT-E. coli lacZfusion gene, virtually abolished splicing in vivo. This behavior 
of the hammerhead ribozyme appeared to be related to its RNA secondary 
structure since the antisense or mutant ribozymes, which have the same 
secondary structure, but different primary sequences, similarly inhibited 
splicing. 
Numerous studies have focused upon the inhibitory effect on splicing of 
hairpins that sequester splice sites, while very few have examined the effect on 
splicing of secondary structures occurring in exons in the absence of splice site 
99 
100 
sequestration. The behavior of the hammerhead ribozyme (described above) is 
particularly interesting because the ribozyme secondary structure occurs in 
exon 2 without sequestering the 31 splice site per se. This thesis project was 
designed to further investigate the effect of RNA secondary structure of exon 2 
on pre-m RNA splicing. We took the approach of genetic suppression, isolating 
yeast mutants which would alleviate the splicing blockage exerted by the 
hammerhead ribozyme. The study was divided into characterization of: 
( 1) cis-acting mutants and (2) trans-acting mutants. 
B. Characterization of BothCis- and Trans-Acting Mutants 
1. Exon 2 Secondary Structure-Specific Splicing Regulation 
Sequencing of the two cis-acting mutations isolated revealed that both 
had single-base alterations in the 10-nt stem Ill of the mutant ribozyme 
construct. The predicted secondary structure of both cis-acting mutants is less 
stable. The two cis-acting mutants partially restore splicing, as evidenced by 
increased (3-galactosidase expression. Our working hypothesis is that a 
specific region of exon 2 needs to be single-stranded for efficient splicing; a less 
stable secondary structure could be more easily unwound by a cellular 
helicase, allowing recognition of the 3' splice site. To test this hypothesis, we 
introduced other mutations into the stem Ill of the ribozyme construct. Each of 
the mutations disrupts base-pairing and decreases the stability of the ribozyme 
structure. All of the ribozyme mutant constructs tested partially restored splicing, 
as evidenced by increased (3-galactosidase expression. Finally, our 
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hypothesis was strengthened by the fact that increasing the stability of the RNA 
structure by restoring complementarity suppresses the ~-gal+ phenotype of the 
cis-acting mutants. 
Our results with the cis-acting mutants isolated from the genetic screen 
and the site-specific mutants constructed later indicate that there might be a 
general phenomenon of exon 2 secondary structure-specific splicing regulation. 
Dominski and Kole (1994) have used antisense 2'-0-methyl 
oligoribonucleotides to block a number of sequences in human ~-globin 
pre-mRNA. They demonstrated that at least 25-nt of ~-globin exon 2 
sequences are required for splicing. Our project is the first such demonstration 
of exon secondary structures blocking splicing in yeast. Secondary structure in 
exon 2 might interfere with pre-mRNA interaction with snRNAs or protein factors. 
One of the snRNAs likely to be affected by secondary structure in exon 2 
adjacent to the 3' splice site is U5 snRNA. The conserved U5 snRNA loop 
sequence has been shown to base pair with exon sequences adjacent to 5' and 
3' splice sites (Newman & Norman, 1992; Wyatt et al., 1992; Sontheimer & 
Steitz, 1993; Newman et al., 1995). Cellular protein factors that are likely to be 
displaced by secondary structure in exon 2 include Slu7 and Prp8, which have 
been shown previously to promote 3' splice site recognition in the yeast 
S. cerevisiae (Frank & Guthrie, 1992; Umen & Guthrie, 1995a, 1995b). 
2. RSS1 Is a Single Copy, Essential Gene and Encodes a 
Putative ATP-Dependent RNA Helicase 
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We have independently recovered two trans-acting mutants. Both were 
found to have a mutation in the same gene. The wild-type RSS1 gene was 
subsequently cloned by complementation of the mutant allele. RSS1 is a single 
copy, essential gene located on Saccharomyces cerevisiae chromosome V. It 
has a single open reading frame of 6,492-nucleotides that could encode a 
264.2 kDa protein. Comparison of the deduced amino acid sequence with the 
protein data base using Blastp revealed that the ASS 1 protein possesses a 
central region of approximately 357 amino acids containing six conserved 
· motifs found in ATP-dependent DNA and ANA helicases (Gorbalenya et al., 
1988, Gorbalenya et al., 1989). This adds a new member to the perhaps most 
exciting group of yeast helicase-like PAP proteins which participate in the 
splicing pathway. This group includes the DEAH-box proteins (PAP2, PRP16, 
and PAP22), and the DEAD-box proteins (PAPS and PAPS). ASS1 is the sixth 
and largest of this group, it is a DEIH-box protein. 
3. Role of ATP-Dependent RNA Helicases in Splicing 
Pre-mRNA splicing requires ATP hydrolysis. Yet, there is no net change 
in the number of phosphodiester bonds in the spliced products. Identification of 
the helicase-like yeast factors in the splicing pathway has helped to decipher 
the highly dynamic, ATP-consuming process of splicing. It is postulated that 
these ATP-dependent RNA helicases utilize the energy derived from ATP 
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hydrolysis for one or both of the following functions: first, facilitating the dynamic 
RNA-RNA interactions in the spliceosome, or second, proof-reading the correct 
conformations to determine the fate of splicing intermediates (either productive 
splicing or discard). Although no RNA helicase activity has been reported for 
any of the above proteins, the RNA-dependent ATPase activity of PRP2 and 
PRP16 has been demonstrated in vitro (Schwer & Guthrie, 1991; Kim et al., 
1992). Moreover, the ATP hydrolysis of PRP2 and PRP16 is accompanied by a 
conformational rearrangement in the spliceosome (Schwer & Guthrie, 1991; 
Kim et al., 1992). 
4. Dominant Suppressor Phenotype vs Recessive 
Temperature Sensitive Phenotype 
The suppressor phenotype of rss1-1 is dominant over the wild-type 
RSS1 as judged by the increased p-galactosidase from ACT-SL-/acZ in the 
heterozygous diploid. The temperature-sensitive phenotype of rss1-1 is 
recessive as judged by the growth of the heterozygous diploid at the 
nonpermissive temperature (37°C). This finding shows that the 
temperature-sensitive phenotype is not required for suppression and that 
suppression does not lead to temperature sensitivity. The step at which 
suppression function acts is separable from the step at which 
temperature-sensitivity results. 
5. Allele Specificity of the Trans-Acting Suppressor 
Phenotype 
104 
The two trans-acting mutants were found to have the same nucleotide 
change in the same gene, indicating allele specificity of the mutant protein. The 
trans-acting suppressor activity is specific for the secondary structure of the 
hammerhead ribozyme rather than primary sequence. This is supported by the 
following: (1) the trans-acting suppressor is able to restore (3-galactosidase 
expression to the same level from the ribozyme, mutant ribozyme, and 
antisense ribozyme constructs (all of which share the same overall RNA 
secondary structures); (2) the trans-acting suppressor is also able to restore 
(3.,-galactosidase expression from the cis-acting mutants 31 and 38, which have 
similar secondary structures to the hammerhead ribozyme; (3) the trans-acting 
suppressor is not able to restore (3-galactosidase expression from 
ACT-SL-/acZ, an 8-nt hairpin construct; and (4) the trans-acting suppressor is 
not able to restore (3-galactosidase expression from p 18, a 24-nt hairpin 
construct. 
6. Effects of the rss1-1 Allele on Expression of the 
ACT-mrz-/acz, ACT-AIVS, and ACT-SL-/acZ Genes 
The rss1-1 allele increases the mature mRNA level of ACT-mrz-/acZas 
demonstrated by RT-PCR analyses. This suggests a splicing enhancement 
effect of rss1-1 on ACT-mrz-/acZ The dramatic increase in (3-galactosidase 
activity from ACT-mrz-/acZin contrast to that from ACT-AIVS, the intron-less 
version of ACT-mrz-/acZ, suggests a splicing-dependent effect of rss1-1. The 
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involvement of RSS1 in splicing is further implicated by rss1-1 decreasing the 
splicing efficiency of ACT-SL-/acZ 
In the presence of the rss1-1 allele, an increase in the mature mRNA 
level of ACT-mrz-lacZ is not accompanied by a concomitant decrease in the 
amount of pre-mRNA and lariat intermediate. In fact, we observed a significant 
increase in pre-mRNA and lariat intermediate. The overall RNA levels, the sum 
of precursor, lariat intermediate, and mature RNA, are increased. We have 
demonstrated that rss1-1 has no effect on pre-mRNA or lariat intermediate 
levels of the endogenous ACT1 gene, which utilizes the same promoter as 
ACT-mrz-/acZfusion gene. Although definitive proof relies on a nuclear runoff 
assay, our current data does not suggest that rss1-1 increases the levels of 
pre-mRNA and lariat intermediate by upregulating transcription. We therefore 
hypothesize that rss 1-1 might promote stability of the pre-mRNA and lariat 
intermediate of ACT-mrz-lacZ 
7. BRR2, SLT22, Snu246p 
During the past year, isolation of the RSS 1 gene has been reported by 
three other laboratories, using three different strategies. First, Noble & Guthrie 
(1996) identified a cold-sensitive splicing-defective mutant, brr2-1, which 
accumulates both pre-mRNAs and lariat intermediates when shifted to 16°C. 
This phenotype suggests that the BRR2 protein might function in one of the 
spliceosome assembly steps prior to the first catalytic reaction. Second, Xu et 
al. (1996) isolated slt22-1 in a genetic screen for synthetic lethality with a mutant 
U2 snRNA that could potentially perturb U2/U6 helix II interaction. The SL T22 
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protein has in vitro ATPase activity and the rate of ATP hydrolysis is stimulated 
by the correct RNA substrate. The ATPase activity was preferentially stimulated 
by annealed wild-type U2/U6 snRNAs. The mutant U2 snRNAs were less 
efficient in stimulating the ATPase activity of SLT22. The mutant slt22 protein 
exhibited less ATPase activity than the wild-type protein in the presence of wild 
type U2/U6 snRNAs. And third, Lauber et al. (1996) identified Snu246p as a 
homologue to the HeLa U5-200kD protein. Like its mammalian counterpart, 
Snu246p is a US snRNP-specific protein. U4, US and U6 snRNAs can be 
co-immunoprecipitated from yeast splicing extracts containing an HA-tagged 
derivative of Snu24Sp with HA-tagged specific antibodies. Lauber and 
colleagues believe Snu246p is an integral component of the US snRNP. 
8. The GRAGR Region Is Likely to Be Involved in RNA Binding 
The suppression o! the hammerhead ribozyme splicing inhibition by 
rss1-1 and the synthetic lethal effect of slt22-1 with a mutant U2 snRNA suggest 
that both mutations alter the RNA binding substrate of the protein. The rss1-1 
mutation alters a residue that is 1 S amino acids from the GRAGR sequence 
(Fig. 2S). The slt22-1 mutation alters a residue that lies 32 amino acids from the 
GRAGR sequence. The fact that the two mutations are in close proximity to the 
conserved GRAGR helicase motif suggests the GRAGR region may be involved 
in RNA substrate binding. This is consistent with the observation of Pause et al. 
(1993) that mutations in the HRIGRAGR sequence drastically reduce elF-4A 
cross-linking to RNA. In addition, some of these mutations affect ATP binding 
and ATPase activity, suggesting a coupling of ATP hydrolysis and RNA binding. 
G858R (rsst-1). E909K (slt22-1) 
::::; xxA 
APTGSGKT DEIH SAT GRAGR 
Billll Central helicase domain 
c:::J Unique region 
,, 
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Figure 25. Schematic of the RSS1 protein. The mutations in rss 1-1 and 





9. Models for rss1-1 Suppression of the Splicing Block Exerted by 
the Hammerhead Ribozyme 
Analysis of the trans-acting mutants suggests two models for rss1-1 
suppression of the splicing block exerted by the hammerhead ribozyme: 
Model I (Gain of Function) 
The wild-type Rss1 protein might recognize U2/U6 snRNA helices 
(Fig. 26). Possibly the mutant rss1-1 protein is able to recognize the 
hammerhead ribozyme, whose secondary structure bears similarity to the 
U2/U6 helices (Fig. 27). The rss 1-1 probably does not recognize any other 
secondary structure (eg., 8-nt hairpin) since the suppressor activity is only 
observed with the ribozyme constructs (see 3.C.6). 
Upon recognition of the hammerhead ribozyme, rss1-1 may be able to 
unwind the secondary structure of the hammerhead ribozyme. This might allow 
the region nearby to the 3' splice site to become single-stranded and, therefore, 
accessible to the splicing machinery. Suppression is achieved by increased 
splicing efficiency. 
Upon recognition of the hammerhead ribozyme, it is also possible that 
rss1-1 may stabilize the pre-mRNA and lariat intermediate of ACT-mrz-/acZ 
(see 5. B.6), and, like prp 16-1, rescue aberrantly formed lariat intermediates 
from a degradative discard pathway that branches from the normal splicing 
Model I 
~RSS1 
~After mutation of RSS1 to rss 1-1 
rss1-1 




Figure 26. Schematic representation of model I for rss1-1 suppression of 
splicing blockage. In this model, the rss1-1 protein has gained the ability to 
recognize the hammerhead ribozyme. Upon recognition, rss1-1 is able to 
exhibit helicase activity and unwind the secondary structure of the 
hammerhead ribozyme. This allows the region nearby the 3' splice site to 





l ~ u-§ Cis Hammerhead Ribozyme 
a=x 
u U CCAGGCUC AAGCGGCCGCCAGCUG- 5' 
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CG GGUCCGACUGAUGAGCCGGCGGUCGAC- 3' 
Figure 27. Secondary structure comparisons of cis-hammerhead 
ribozyme and U2/U6 snRNAs. Extensive similarity is observed. Both 
have three stem regions (left, upright, and right) and a core region in the 
center that is not paired. 
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pathway (Burgess & Guthrie, 1993). We may be able to test this by compairing 
the stability of the ACT-mrz-lacZ pre-mRNA and lariat intermediate in the RSS1 
and rss1-1 background. 
The gain of function of rss1-1 to recognize the hammerhead ribozyme 
can be tested two ways: First; one can .. examine ATPase activity (measured by 
release of free phosphate from ATP hydrolysis) of the mutant or wild-type 
protein in the presence of the hammerhead ribozyme or U2/U6 snRNA. Since 
the rate of ATP hydrolysis of an RNA helicase is presumably stimulated by its 
correct RNA substrate (Burgess et al., 1990; Xu et al., 1996), the prediction is 
that ATPase activity of the mutant rss1-1 protein would be preferentially 
stimulated by the hammerhead ribozyme, whereas ATPase activity of the wild 
type protein would be preferentially stimulated by U2/U6 snRNAs. Second, it is 
possible that the mutant rss1-1 protein could physically associate or bind to the 
hammerhead ribozyme while the wild-type protein could not. We could test this 
by means of gel shift or crosslinking analyses. 
Model II (Loss of Function) 
The wild-type RSS1 protein might recognize both U2/U6 helices and 
hammerhead ribozyme secondary structures (due to the high similarity between 
them) (Fig. 27 & Fig. 28). Inhibition of ACT-mrz-/acZ splicing could be due, not 
only to the secondary structure of the hammerhead ribozyme, but also steric 
interference of the bulky RSS1 protein-hammerhead ribozyme RNA complex 
Model II 
RSS1 
R After mutation of RSS1 to rss1-1 
~ rss1-1 
Figure 28. Schematic representation of model II for rss 1-1 suppression of 
splicing blockage. In this model, the wild-type RSS1 protein recognizes 
the hammerhead ribozyme secondary structure. Inhibition fo splicing is 
not only due to the secondary structure of the hammerhead ribozyme, but 
also due to steric interference of the bulky RSS1 protein-hammerhead 
ribozyme RNA complex blocking the nearby 3' splice site. We have 
mutated the protein so that rss1-1 cannot bind to the hammerhead 
ribozyme. This partially alleviates the splicing blockage. 
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blocking the nearby 3' splice site. In this model the rss1-1 protein would not 
bind to the hammerhead ribozyme. The consequence of this may be that 
splicing blockage is partially relieved, although never fully, since splicing is still 
inhibited by the secondary structure of ribozyme. 
The second model predicts. that an equally stable, but .different secondary 
structure would not block splicing as much as the hammerhead ribozyme. This 
is because splicing would only be inhibited by the effect of the secondary 
structure but not the bulky protein-RNA complex. This is supported by our 
results with the third cis-acting mutant p18, which has the potential to form a 
24-nt stem loop motif, and has a AG very similar to that of the hammerhead 
ribozyme. The second model could also explain the allele specificity of rss1-1. 
Neither wild-type nor mutant protein might recognize any secondary structure 
other than the U2/U6 or hammerhead ribozymes. Therefore, trans-acting 
suppressor activity is only observed with the hammerhead ribozyme, but not 
with other secondary structure constructs that we tested (see 3.C.6 & 4.C.). We 
can test model II by testing whether the hammerhead ribozyme binds to or 
crosslinks with the wild-type Rss1 protein, but not the mutant rss1-1 protein. 
During our genetic screen for suppressors of splicing inhibition, we 
independently identified rss 1-1 twice. This suggests that the rss 1-1 allele is 
highly specific for what we have asked the cell to accomplish, survival and 
suppression of the ribozyme. RSS1 is an essential gene. Only a small number 
of changes may be tolerable. Among them, only one may allow rss1-1 to gain a 
specific activity to recognize the secondary structure of the hammerhead 
ribozyme (model I). Alternatively, only one may allow rss1-1 to lose the ability to 
bind to the hammerhead ribozyme (model II) without knocking out its essential 
function. 
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C. Implication of Hammerhead Ribozyme Studies in Yeast 
In the past, we have tried virtually every scheme possible to get 
hammerhead ribozymes to function in yeast. We have expressed the ribozymes 
under various promoters, including inducible GAL, U2 snRNA, or-the very strong 
RNAseP-RNA Pol Ill promoter. We have also positioned the ribozymes in a 
variety of locations in several different transcripts. We have attempted 
co-localization strategies, designed to maximize effective interactions of 
ribozymes and target RNAs. We have utilized very sensitive assay systems, 
including B-galactosidase screening and positive selection for resistance to 
alpha aminoadipate. In spite of this immense effort, we have not been able to 
demonstrate hammerhead ribozyme cleavage of target RNA in yeast. 
There are several potential reasons why the ribozymes fail to cleave 
target RNA in yeast. One of them is that the ribozymes might not fold in the 
correct conformation. The isolation of the cis-suppressors suggests that at least 
the stem Ill secondary structure of the mutant ribozyme is present. Since 
cis-mutations disrupt the base pairing in stem Ill of the mutant ribozyme, we 
believe that stem Ill was able to form and inhibit splicing to the adjacent 3' splice 
site in vivo. 
Failure to detect ribozyme activity in yeast has also been related to 
protein- mediated inhibition of ribozyme function. In the second model that we 
proposed for the trans-acting suppressor activity, the wild-type Rss1 protein 
would bind to the hammerhead ribozyme. We considered the possibility that 
Rss1 might inhibit ribozyme function in yeast. Since the second model predicts 
that mutant rss1-1 protein does not bind to the hammerhead ribozyme, we 
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examined the ribozyme cleavage activity in rss1-1 yeast cells. Our result 
revealed no ribozyme cleavage in rss1-1 yeast cells. Future testing of other 
mutant alleles of RSS1 will be necessary to confirm that the Rss1 protein does 
not mediate inhibition of ribozyme function in yeast. 
D. Future Directions 
Two models for rss1-1 suppression of the splicing blockage were 
proposed in this dissertation. Future testing of the models will yield insight 
concerning how specific RNA structure recognition is associated with its 
biochemical activities (such as ATP hydrolysis and RNA unwinding). 
None of the five yeast PAP proteins involved in splicing has been 
demonstrated an RNA unwinding activity in vitro. It is possible that these 
splicing factors may only unwind specific RNA substrates. We have shown in 
our system that rss1-1 might unwind the secondary structure of the ribozyme. 
Unless other auxiliary protein factors are required for this activity, we may be 
able to demonstrate unwinding of the ribozyme by rss 1-1 in vitro. 
Our experimental system, in which the RNA secondary structure 
encoding sequences are cloned immediately adjacent to the 3' splice site of the 
ACT-/acZfusion gene, may serve as an in vivo test tube for assaying the 
helicase activity and determining the RNA substrate of the Rss1 protein. The 
level of lacZ expression depends upon the splicing of the ACT intron, which in 
turn, relies upon the helicase activity of the protein. It has been suggested that 
the helicase activity of a putative RNA helicase is coupled with its correct RNA 
substrate recognition (Fuller-Pace, 1994). We can then determine the RNA 
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substrate of Rss1 by measuring the lacZ expression. Xu et al (1996) 
demonstrated via synthetic lethality that U2/U6 snRNAs may be the target of the 
RSS1 protein. To further investigate this, we can synthesize a DNA fragment, 
which when transcribed, could potentially fold into the U2/U6 helices. We can 
then clone this U2/U6 hybrid DNA fragment adjacent to the 3' splice site of the 
ACT-/acZfusion gene and assay for the level of lacZ expression in the RSS1 or 
rss1-1 background. If U2/U6 is the correct substrate of RSS1 protein, the 
secondary structure would be unwinded, splicing would not be inhibited, and 
/acZwould be expressed. Moreover, we could determine the region of U2/U6 
snRNAs that is critical for its interaction with the Rss1 protein by generating a 
pool of randomly mutagenized U2/U6 hybrid DNA fragments in vitro. We could 
then clone these fragments immediately adjacent to the 3' splice site of a fusion 
ACT-URA3 gene. This fusion gene would be similar to the ACT-lacZ except that 
lacZ is replaced by the yeast URA3 gene. Any mutation taking place in the 
region of U2/U6 that may be critical for Rss1 interaction would cause the Rss1 
protein not able to unwind the secondary structure of U2/U6 helices. Splicing 
would be inhibited and URA3 gene expression would be repressed. This 
allows the selection of yeast cells that contains the mutant construct on 5-FOA 
medium. 
CHAPTER 6 
SEARCH FOR MAMMALIAN BINDING PROTEINS THAT INTERACT 
WITH HIV-1 CRS, INS-1, AND TAR RNA ELEMENTS 
A. INTRODUCTION 
1. HIV CRS, INS-1, and TAR 
Investigation of the human immunodeficiency virus (HIV) life cycle has 
revealed a complex pattern of gene expression. The expression of all the HIV 
genes from one promoter is accomplished by the generation of alternatively 
spliced mRNAs grouped into three size classes: full length, intermediate, and 
small (Muesing et al., 1985; Schwartz et al., 1990). Early in the HIV life cycle, 
the full length and intermediate RNAs encoding the structural proteins (Gag, 
Pol, and Env) appear to be sequestered within the nucleus; the multiply spliced, 
short RNAs are efficiently transported to the cytoplasm in the absence of Rev 
(Emerman et al., 1989; Hadzopoulou-Cladaras et al., 1989; Hammarskjold et 
al., 1989; Malim et al., 1989). Later in the HIV life cycle, expression of Rev 
promotes export from the nucleus of full length and intermediate RNAs and 
subsequently permits synthesis of the viral structural proteins (for reviews, 
Cullen & Greene, 1989; Pavlakis & Felber, 1990; Rosen & Pavlakis, 1990). 
Using a heterologous beta-globin system, Chang and Sharp (1989) have 
shown that a non-HIV mRNA can be made Rev-responsive by adding both 
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Rev-responsive element (RRE) (cis-acting Rev targeting sequence) and a 
mutation of either the splice donor or acceptor site of the intron. This led to the 
hypothesis that sequestration of HIV structural mRNA in the nucleus is due to 
the inefficiency of the splicing reaction. 
However,. other studies have found that additional elements present 
within the HIV genome contribute to sequestration of mRNA for HIV structural 
proteins in the nucleus. Using a heterologous system, Rosen et al. (1988) have 
demonstrated that several regions within env contain negative regulatory 
elements. These elements, when present within the 3' UTA of a reporter gene 
(CAT), block gene expression. In addition, negative effect of these sequences 
is relieved by addition of Rev protein in trans. Deletion of them resulted in an 
increase in CAT gene expression. Further examination of gag and pol genes 
revealed that both genes also contain cis-acting repressive sequences (CRS). 
CRS blocks gene expression when present within the 3' UTR of a heterologous 
gene transcript (Cochrane et al., 1991). A 490-bp region in pol was found to 
have the strongest repressive effect. Deletion mutagenesis defined a minimal 
270-bp element within the 3' portion of pol that was capable of inhibiting gene 
expression to a similar extent as that observed with the 490-bp fragment. 
Incubation of RNA corresponding to the 270-bp CRS element with nuclear 
extract prepared from human T-cells reveals a strong and specific interaction 
with several cellular factors (Olsen et al., 1992). Monoclonal antibody raised 
against hnRNP C reacted with the CRS RNA-protein complex, suggesting that 
hnRNP C (or a closely related gene product) interacts with CRS. This finding 
raised the possibility that the CRS elements elicit nuclear entrapment of viral 
RNA through formation of RNA-protein complexes that are not accessible to 
nuclear export pathways. 
119 
Schwartz et al. (1992) identified a 218-bp fragment in the HIV genome, 
referred as INS-1 (inhibitory sequences), which has a similar inhibitory effect as 
the CRS elements. INS-1 repressed heterologous gene expression when 
present in cis. The inhibitory effect of INS-1 was counteracted by the positive 
effect mediated by the Rev-RAE interaction. 
TAR is the cis-acting sequences that interact with the regulatory Tat 
protein (Rosen et al., 1985). It is required for Tat trans-activation of HIV gene 
expression. TAR RNA is present in the 5' UTA of all HIV-1 mRNAs. It forms a 
stable stem-bulge-loop structure (Muesing et al., 1987). Mutations that disrupt 
the stem, affect the loop or bulge, or destroy the overall secondary structure of 
the RNA interfere with Tat trans-activation (Feng & Holland, 1988; Roy et al., 
1990). 
Several lines of evidence suggest that the direct interaction between Tat 
and TAR constitutes only one of the components involved in the overall Tat 
trans-activation. The most siginicant of these is the finding that the mutations to 
the terminal loop of TAR that strongly inhibit in vivo function have little or no 
effect on in vitro Tat binding (Dingwall et al., 1989). It therefore appears that 
cellular factors probably cooperates with Tat in the overall trans-activation 
process. 
2. Translation Initiation 
The translation of the vast majority of cellular mRNAs is initiated by a 
number of consecutive biochemical reactions. The first protein to bind to mRNA 
appears to be elF-4F, a heterotrimer composed of elF-4E, elF-4A, and p220. 
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el F-4E is a 24-kD polypeptide which specifically interacts with the m 7 G cap 
structure at the 5' end of eukaryotic mRNA (8annerjee 1980). Following the 
binding of elF-4F to the cap structure of the mRNA, elF-48 associates with 
elF-4F. elF-48 is thought to cooperate with elF-4A in RNA binding and stimulate 
the helicase activity of elF .. 4A. elF-4A, ·the prototype of the DEAD box RNA 
helicases, is an RNA-dependent ATPase. It is thought to use the energy 
derived from ATP hydrolysis to unwind potential secondary structures in the 
5' UTA. The next step is the binding of the mRNA to the 438 initiation complex, 
which is composed of elF-2, GTP, initiator Met-tRNA, and 40 8 ribosomal 
subunit. The 43 8 initiation complex scans along the 5' UTA. Local RNA 
secondary structure is relaxed during scanning, if it is not, it impedes the 
movement of the ribosome on the mRNA. Once an appropriate match is made 
between the anticodon of the initiator tRNA and the AUG start codon, GTP is 
hydrolyzed. Release of the initiation factors from the surface of the 408 subunit 
allows for 608 ribosomal subunit to join. 
3. Regulation of Translation Initiation 
Initiation is the rate limiting step of translation (Jagus et al., 1981 ). It has 
emerged as an important step in the regulation of specific genes in both 
prokaryotic and eukaryotic organisms (8onerberg, 1988). Translation of 
specific genes can be regulated through particular features of secondary 
structure of their mRNA transcripts. 
In eukaryotes, the best characterized example of gene regulation by 
translational initiation is the protein-RNA interaction of ferritin mRNA. Ferritin 
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synthesis is maintained at a very low basal rate when extracellular iron levels 
are low. The switch to iron-rich medium induces up to a 50-fold increase in 
ferritin translation, with little or no change in the level of the mRNA. All ferritin 
mRNAs thus far examined contain a conserved stem loop motif, called IRE 
(iron-responsive element). IRE is required in cis .for translational control of 
ferritin expression (Caughmann et al., 1988; Hentze et al., 1987a). A 
heterologous mRNA is rendered iron responsive when IRE is cloned into the 
5' UTR region, suggesting that the presence of an IRE in the 5' UTR is sufficient 
for regulation (Hentze et al., 1987b). In vitro studies suggest that IRE serves as 
the binding site for a 90-kD cytoplasmic binding protein referred to as the 
IRE-BP (iron-responsive element-binding protein) (Rouault et al., 1988). The 
IRE binding activity of IRE-BP correlates with the iron status of the cell 
(Haile et al., 1989): IRE-BP extracted from cells treated with an iron chelator has 
significantly higher affinity for the IRE than IRE-BP extracted from cells treated 
with iron 
IRE-BP/IRE may sterically block one or more early steps of translation 
initiation, thereby repressing translation. Thus, IRE-BP/IRE may represent the 
first physiological example of a more general mechanism for translational 
blockage imposed by the RNA/protein complex. This hypothesis was tested by 
inserting high affinity RNA-binding sites for the bacteriophage MS2 coat protein 
or the spliceosomal protein U1A into the 5' UTR of capped chloramphenicol 
acetyltransferase(CAT) transcripts (Stripecke & Hentze, 1992). In the absence 
of these RNA-binding proteins, CAT mRNA is efficiently translated. Addition of 
purified MS2 coat protein or U1A spliceosomal protein causes repression of 
CAT synthesis in rabbit reticulocyte and wheat germ in vitro translation systems. 
The translational repression is dosage dependent and could be relieved by 
removal of repressor. 
4. Objectives 
This study was divided into two parts: 
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I. Identify mammalian protein factor(s) that bind to HIV CRS or 
INS-1 
There has been much interest in why HIV structural genes are not 
expressed in the absence of Rev protein early in the viral life cycle. It has been 
proposed that inefficient splicing of HIV mRNA contributes to nuclear 
sequestration of full length or intermediate transcripts encoding the structural 
proteins. It has also been proposed that nuclear retention of HIV RNA was 
mediated by cis-acting repressive sequences or inhibitory sequences. Recent 
studies have identified a 270-bp CRS element in the pol gene and a 218-bp 
INS-1 element in the 5' end of gag gene. Both have the ability to repress 
heterologous gene expression when present in cis. It is thought that they 
function through formation of RNA-protein complexes that are not accessible to 
nuclear export pathways. 
We decided to use a genetic approach to identify protein factor(s) that 
may bind to CRS or INS-1 element. We used a counterselectable yeast gene 
URA3, whose expression causes toxicity in the presence of 5-FOA 
(5-Fluoroorotic acid). We fused HIV CRS or INS-1 elements in cis with yeast 
URA3 transcripts (Fig. 29). S. cerevisiae cells were transformed with a 
mammalian cDNA library. If a protein factor (encoded by mammalian cDNA) 
URA3 ~ CRS or INS-1 ~ polyA I 
5-FOA sensitivity 
URA3 poly A 
Retaining of the URA3 transcripts within the nucleus 
5-FOA resistance 
Figure 29. 'Strategy to clone HIV-1 CRS or INS-1 RNA binding proteins. 
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binds to CRS or INS-1 elements, transcripts will be retained within the nucleus. 
URA3 gene expression will be inhibited. Yeast transformants deficient in URA3 
gene expression will be positively selected by 5-FOA resistance. 
II. Develop a general technique to clone protein factor(s} that 
interact with an RNA fragment of interest 
Translation initiation requires scanning of 40S ribosomal subunit along 
the 5' UTR of mRNAs until the first AUG is reached. Moderately stable 
secondary structures in the 5' UTR can be relaxed by translation apparatus, 
ensuring efficient scanning of the 40S ribosomal subunit. However, if the 
secondary structure is bound to protein(s) to form an RNA-protein complex, 
translation initiation could be sterically blocked. The translation blockage 
imposed by an RNA/protein complex has been examplified by IRE/IRE-BP and 
several experimental systems. 
We decided to use these informations to construct a system that would 
allow us to clone protein factor(s) which interact with an RNA fragment of 
interest (Fig. 30). An RNA fragment of interest was placed into the 5' UTR of 
yeast URA3 gene. If a protein factor encoded by mammalian cDNA binds to the 
RNA fragment and form a stable RNA-protein complex, translation initiation will 
be sterically blocked. URA3 gene expression will be inhibited. Yeast 
transformants deficient in URA3 gene expression will be seclected by 5-FOA 
resistance. 
We were interested in identifying cellular factor(s) that bind to HIV TAR. 
We cloned TAR into the 5' UTR of the yeast URA3 gene, transformed the yeast 
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! RNA unwinding ! No RNA unwinding 
U RA3 gene expression 
5-FOA sensitivity 
! 
No URA3 gene expression 
5-FOA resistance 
Figure 30. Strategy to clone protein factor(s) that interact with an 
RNA fragment of interest. 
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cells with a mammalian cDNA library, and selected for transformants whose 
URA3 gene expression was inhibited {5-FOA resistance) as in the first part of 
this study. Translation blockage could resulted from a RNA {TAR)/protein 
complex. 
B. RESULTS 
1. HIV-1 INS and CRS Binding Proteins 
The 218-bp INS-1 fragment derived from pBKBH10S by polymerase 
chain reaction, was first inserted -30 bp upstream of the URA3 start codon in 
plasmid p810. The 270-bp CRS fragment kindly provided by Craig Rosen, was 
inserted into the same site in URA3 in an analogous construct. We performed a 
Northern blot analyses to confirm that INS-1 (and CRS) was in the 5' UTA 
region of the URA3 transcript. We were not able to demonstrate that 
random-primed labelled INS-1 or CRS probes hybridized to the respective 
URA3 transcripts (data not shown) 
As an alternative approach, INS-1 or CRS fragments were each inserted 
-30-bp downstream of the URA3 termination codon in p81 O plasmid. 
Subsequent northern blot analyses showed that at least the INS-1 fragment 
was present in cis with the URA3 mRNA. JM43 cells harboring either 
p810-CRS or p810-INS were transformed with a rat brain cDNA library (cloned 
into yeast expression vectors) (Colicelli et al., 1989). The cells were plated on 
CSM -Trp -Leu plates to select for the transformants. After 3 to 4 days growth on 
CSM minus medium, the colonies were replica plated to 5-FOA plates. 
127 
Approximately 11, 100 colonies were screened; 72 colonies were 5-FOA 
resistant. To confirm these colonies were 5-FOA resistant, they were restreaked 
on 5-FOA plates and tested for their ability to generate single colonies. 
To determine whether 5-FOA resistance was due to the transformed rat 
brain cDNAplasmid, each·of the 72 colonies was-inoculated into CSM -Trp 
+Leu liquid medium to be cured of the mammalian cDNA plasmid. The cells 
were then tested for the ability to grow on CSM -uracil plates. If the cells 
remained 5-FOA resistant in the absence of the rat brain cDNA plasmid, i.e., 
unable to grow on CSM -uracil medium, then the 5-FOA resistance phenotype 
was not due to the interaction of a factor encoded by rat brain cDNA with the 
CRS or INS element. If the cells became 5-FOA sensitive in the absence of the 
rat brain cDNA plasmid, i.e., capable of growing on CSM -Ura medium, the 
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factor encoded by rat brain cDNA was able to interact with either CRS or INS 
element and inhibited the expression of URA3 gene. Unfortunately, 5-FOA 
resistance did not correlate with the presence of the rat brain cDNA library 
plasmid in any of the 72 colonies. 
2. HIV TAR Binding Protein 
We also attempted to clone HIV TAR interacting protein factor(s). The 
70-bp TAR fragment (with Pstl site engineered in both ends) was constructed 
by PCR of two overlapping oligos. The resulting PCR fragment was digested 
with Pstl and inserted into the pBluescript vector. The 70-bp Pstl-Pstl fragment 
was then cloned into pB10, -30-bp upstream of the URA3 start codon, 
producing plasmid pB5-TAR. When JM43 strain was transformed with p85-TAR 
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was transformed into JM43, 5-FOA resistance phenotype was conferred. 
Transform ants containing the parent plasm id pB 1 O did not have this phenotype. 
This indicates that the presence of HIV TAR alone inhibits URA3 gene 
expression. It is likely that TAR, a stable stem loop motif in the 5' UTA of URA3, 
impeded scanning of the 40s initiation complex. 
C. DISCUSSION 
Yeast has become an extremely popular and successful model system 
for understanding eukaryotic biology. The intracellular organization of these 
single cell eukaryotes is much like the cells of more complex organisms. 
Conservation is substantial for many basic biologic properties: cytoskeletal 
organization, subcellular organelles, secretion, receptor and second 
messenger systems, metabolic regulation, and chromosome mechanics. The 
exchangebility of proteins of analogous function in yeast and humans has been 
demonstrated in several cases. For example, mammalian ras genes 
complement yeast ras mutants and vice versa. Human CDC2 gene was cloned 
by complementation of a cdc2 mutation in S. pombe. Since human genes 
cannot be directly cloned by simple complementation in mammalian systems, 
new human genes are often cloned by their complementation of yeast 
mutations. In addition, yeast may also serve as the host in which viral 
(eg. HIV-1) and human DNA sequences are brought together via yeast vectors. 
In the first part of this study, we took a genetic approach to clone 
mammalian protein factor(s) that interact with HIV CRS or INS-1 elements. 
Unfortunately, all the 5-FOA resistant yeast colonies identified were false 
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positives, presumably due to background growth of wild- type cells. This was 
demonstrated by the persistence of 5-FOA resistance phenotype even after the 
loss of mammalian cDNA plasmids. Our failure to identify a mammalian cDNA 
encoded protein factor that interacts with either CRS or INS-1 RNA sequences 
could be due to the requirement for more than one factor to efficiently sequester 
in the nucleus the transcripts carrying CRS or INS-1. If this is the case, we 
would never recover them since only one plasmid is transformed into yeast at a 
time. Alternatively, despite much conservation between yeast and human 
protein functions, there may be no yeast analogues of HIV-1 CRS and INS-1 
RNA-binding proteins. Previous work demonstrating the function of the HIV 
CRS or INS-1 was undertaken only in mammalian systems. 
In the second part of our study, we attempted to develop a method for 
cloning protein factor(s) that interact with an RNA fragment of interest. Our 
hypothesis was that translation initiation could be blocked by an RNA/protein 
complex in the 5' UTR. However, our result with HIV TAR suggested that URA3 
gene expression was inhibited by TAR itself, before transformation of the yeast 
with a mammalian cDNA library (containing the putative binding protein). There 
are two explanations for this result. First, yeast could have a factor that binds to 
HIV TAR. The unknown yeast factor could be a homologue of a mammalian 
factor whose binding with HIV TAR is biological significant for HIV life cycle. 
Alternatively, the yeast factor may bind to TAR RNA, but without any biological 
relevance. Second, the TAR stem loop secondary structure by itself blocked 
translation initiation. It is possible that TAR, with its stable stem loop secondary 
structure, could not be unwound by the translational machinery. TAR by itself 
sterically hindered scanning of the 408 initiation complex and inhibited 
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translation initiation. If this is true, our approach to clone RNA interacting factors 
could work with RNAs that have weaker secondary structure than HIV TAR. 
D. MATERIALS AND METHODS 
1. Yeast Strain 
JM43 (Mat leu2-3, 112 ura3-52 trp1-289 his4-580) was kindly provided 
by Joan mcEwen. 
2. Growth Media 
YPD, CSM minus mediua are prepared as described in section 3.A.2. 
5-FOA plates were made according to the methods of Treco & Lundblad (1993). 
1 g of 5-FOA powder, 500 ml dH20, 5 ml 2.4 mg/ml uracil solution were mixed 
and stirred with low heat -1 hour until completely dissolved. The mixture was 
filter sterilized. 1.7 g YNB-AA/AS, 5 g (NH4)2, 20 g dextrose, 20 g agar, and 
1.3 g uracil dropout premix were mixed in H20 to a final velum of 500 ml. The 
mixture was autoclaved. When the molten agar cools to -65°C, the sterile 
5-FOA/uracil solution was gently added to the uracil dropout medium by pouring 
it down the inside wall of the flask containing the latter. The mixture was swirled 
gently to mix and poured into the plates. 
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3. Recombinant Plasmids 
INS-1 was derived from pBKBH10S (containing HIV proviral DNA except 
L TR) by polymerase chain reaction. It was subsequently cloned into Pst1 site in 
pBluescript vector. The Pst1 flanking-INS-1 fragment was then cloned 
'30 bp downstream of URA3 termination codon in p810 to result in p810-INS. 
p810 is derived from cloning yeast Trp1 into multiple cloning sites of PRS416. It 
therefore allowed two selections for yeast transformants, on CSM -Trp and on 
CSM -Ura. 
4. Yeast Transformation 
Please refer to section 2.8.3. 
5. Northern Blot Analysis 
Please refer to section 2.8.8. 
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